You are here: University of Sydney / Sydney Medical School / Our people / Professor Peter McIntyre 

Professor Peter McIntyre

Professor
Child and Adolescent Health , Children's Hospital, Westmead
National Centre for Immunisation Research & Surveillance of Vaccine Preventable Diseases (NCIRS)

Telephone +61 2 9845 1417
Fax +61 2 9845 1418

Website Related website
Curriculum vitae Curriculum vitae

Map

Biographical details

My research background is in paediatric infectious diseases, in which I have a clinical appointment at the Childrens Hospital, Westmead and in the epidemiology of vaccine-preventable diseases, which was the subject of my PhD in the School of Public Health on invasive Hib disease. As Director of the National Centre for Immunisation Research and Surveillance of Vaccine-Preventable Diseases, my knowledge and experience covers a wide range of topics with special prominence to pertussis and pneumococcal disease and use of the Australian Childhood Immunisation Register for vaccine effectiveness and data linkage studies

Back to Top

Research interests

My research interests are broadly in the area of the epidemiology of vaccine-preventable diseases (VPDs), including measurement of disease burden pre vaccine introduction, measurement of immunisation coverage and measurement of the impact of vaccines post introduction. I also have a strong record in clinical vaccine trials and was the Chief Investigator for a now completed multi-site national randomised vaccine trial of pertussis vaccine to newborns funded by the NHMRC. My major specific interests are in bacterial VPDs, including Haemophilus influenzae type b, pneumococcus and pertussis, including measurement of vaccine effectiveness and risk factors using case-control studies and linked data sets and post implementation evaluation of vaccine programs

Back to Top

Teaching and supervision

I am a major contributor to the Vaccines in Public Health elective provided within the Master of Public Health course run through the National Centre, teach in the first two years of the Graduate Medical Program in immunisation and the microbiology of pneumonia and in the fourth year in immunisation for students in Paediatrics and Child Health. I am frequently asked to deliverteaching sessions for various professional groups

Back to Top

Current projects

Post implementation economic assessment of vaccine programs (ARC grant with Dr A Newall, UNSW)

Evaluation of immunisation programs in children and adults especially pertussis and pneumococcal disease

The Paediatric Active Enhanced Disease Surveillance (PAEDS) hospital-based network in 5 tertiary referral paediatic hospitals throughout Australia

Data linkage project including over 1 million children in New South Wales and Western Australia - linked data on notifications, hospitalisations, deaths and vaccination status in Indigenous and non-Indigenous children

Back to Top

Associations

Royal Australian College of Physicians

Faculty of Public Health Medicine

Australasian Society for Infectious Diseases

European Society for Paediatric Infectious Diseases

Back to Top

Awards and honours

Fellow, RACP

Fellow, AFPHM

Fellow, Public Health Association

Back to Top

In the media

Frequent commentator in mainstream print, radio and television

Frequent contributor to other fora such as medical newspapers, journal commentary, websites

Back to Top

Selected grants

2017

  • Assessing acellular pertussis vaccine effectiveness: integrating transmission models, genetics and cohort data to inform policy; McIntyre P; National Health and Medical Research Council (NHMRC)/Project Grants.

2016

  • Reducing vaccine preventable diseases in children: using national active hospital-based surveillance to evaluate and improve immunisation program performance; Macartney K, Blyth C, Marshall H, Leask J, McIntyre P, Elliott E, Snelling T, Clark J, Buttery J, Wood N; National Health and Medical Research Council (NHMRC)/Partnership Projects.
  • Quantifying the effectiveness of pertussis vaccine in older adults; Liu B, McIntyre P, Hayen A, Newall A, Quinn H; National Health and Medical Research Council (NHMRC)/Project Grants.

2015

  • Vaccination timeliness in Aboriginal and non-Aboriginal infants: risk factors for delayed vaccination and impact on disease burden—a record linkage study; McIntyre P; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • Providing the evidence to guide adult immunisation strategies: a novel approach using a large prospective cohort study and record linkage; McIntyre P, Liu B, McIntyre P; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Better use of vaccines for improved ear and hearing health of Indigenous children; Leach A, McIntyre P, Torzillo P; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Q fever: How common is it and how can we best prevent it Research to inform Q fever vaccine policy in Australia and Internationally; Wood N, Gidding H, McIntyre P, Nissen M, Durrheim D, Norris J, Bosward K, Heller J; National Health and Medical Research Council (NHMRC)/Project Grants.

2012

  • Health trajectories in urban Aboriginal children: the SEARCH Study; Banks E, Eades S, D'Este C, Bailey S, Redman S, Purcell A, Williamson A, Gunasekera H, McIntyre P, Clapham K; National Health and Medical Research Council (NHMRC)/Project Grants.
  • CRE - Immunisation in under studied and special risk populations:closing the gap in knowledge through a multidisciplinary approach; MacIntyre C, McIntyre P, Booy R, Leask J, Wood N, Jones C, Dwyer D, Menzies R; National Health and Medical Research Council (NHMRC)/Centres of Research Excellence.

2011

  • Evolution of pertussis epidemics and effect of genotypes on infection outcomes and immunisation; Lan R, Marshall H, Sintchenko V, Gilbert G, McIntyre P, Marshall H, Wood N; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Making a difference: building research capacity for health interventions to improve Aboriginal health; Eades S, Bailey S, Banks E, Butow P, Cass A, D Este C, Jan S, Kaldor J, Kippax S, Leask J, McIntyre P, Nutbeam D, Redman S, Sanson-Fisher R, Thompson S; National Health and Medical Research Council (NHMRC)/Strategic Awards: Capacity Building Grants in Population Health Research.

2009

  • Characterisation of H1N1 Influenza 09 in hospitalised children using Paediatric Active Enhanced Diseases Surveillance; Elliott E, Booy R, McIntyre P, Zurynski Y, Wood N; National Health and Medical Research Council (NHMRC)/Special Call Research On H1N1 Influenza.
  • Immunogenicity and safety of birth pertussis vaccination; McIntyre P, Marshall H, Rowe J, Nolan T, Nolan T, Wood N, Marshall H; National Health and Medical Research Council (NHMRC)/Project Grants.

2008

  • Ear health, hearing, speech and language development in urban Aboriginal children; Eades S, McIntyre P, Oates K, Daniels J, Woolfenden S; National Health and Medical Research Council (NHMRC)/Project Grants.

2007

  • Making a difference - Interventions for Aboriginal health improvement; Kaldor J, Kippax S, Eades S, D'Este C, Banks E, Bailey S, Banks E, Butow P, Cass A, D Este C, Jan S, Kaldor J, Kippax S, Leask J, McIntyre P, Nutbeam D, Redman S, Sanson-Fisher R, Thompson S; National Health and Medical Research Council (NHMRC)/Capacity Building Grant.

2006

  • Search-Study Of Environment On Aboriginal Resilience And Child Health; Banks E, Craig J, Clapham K, Kippax S, Taylor R, Bailey S, Banks E, Cass A, Clapham K, Daniels J, Eades S, Kippax S, McIntyre P, Parker A, Raphael B, Redman S, Vincent F; National Health and Medical Research Council (NHMRC)/Strategic Awards: A Healthy Start to Life for Aboriginal and Torres Strait Islander Children.

2005

  • The immunogenicity of 7-valent pneumococcal conjugate vaccine in sick elderly people for whom vaccine is not registered.; McIntyre P, Gilbert G, Sullivan J, Lindley R, MacIntyre C; National Health and Medical Research Council (NHMRC)/Project Grants.
Back to Top

Selected publications & creative works

Download citations: PDF RTF Endnote

Books

  • Hull, B., Lawrence, G., McIntyre, P., MacIntyre, C. (2002). Immunisation Coverage: Australia 2001. Australia: University of Sydney.

Book Chapters

  • McIntyre, P., Macartney, K., Gilroy, N., Lester, R. (2010). Immunisation. In A Yung, D Spelman, A Street, J McCormack, T Sorrell, P Johnson (Eds.), Infectious Diseases: A clinical approach, (pp. 648-666). Melbourne: IP Communications.
  • McIntyre, P., Lester, R. (2005). Immunisation. In A Yung, D Spelman, A Street, J McCormack, T Sorrell, P Johnson (Eds.), Infectious Diseases: A clinical approach, (pp. 560-577). Melbourne: IP Communications.
  • McIntyre, P. (2003). Pneumococcal disease. In Thomson (Eds.), The health of Indigenous Australians, (pp. 384-396). VIC: Oxford University Press.
  • McIntyre, P. (2000). Meningitis. In Virginia A. Moyer et al (Eds.), Evidence Based Pediatrics and Child Health, (pp. 197-205). BMJ Books.

Journals

  • Hull, B., Hendry, A., Dey, A., Beard, F., McIntyre, P., Brotherton, J. (2019). Immunisation coverage annual report, 2015. Communicable diseases intelligence (2018), 43(43), 1-45.
  • Gunasekera, H., Miller, H., Burgess, L., Chando, S., Sheriff, S., Tsembis, J., Kong, K., Coates, H., Curotta, J., Falster, K., McIntyre, P., Craig, J., et al (2018). Agreement between diagnoses of otitis media by audiologists and otolaryngologists in Aboriginal Australian children. Medical Journal of Australia, 209(1), 29-35. [More Information]
  • Moore, H., Fathima, P., Gidding, H., de Klerk, N., Liu, B., Sheppeard, V., Effler, P., Snelling, T., McIntyre, P., Blyth, C. (2018). Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study. Vaccine, 36(28), 4062-4069. [More Information]
  • Karki, S., Muscatello, D., Banks, E., MacIntyre, C., McIntyre, P., Liu, B. (2018). Association between body mass index and laboratory-confirmed influenza in middle aged and older adults: a prospective cohort study. International Journal of Obesity, 42(8), 1480-1488. [More Information]
  • Edirisuriya, C., Beard, F., Hendry, A., Dey, A., Gidding, H., Hueston, L., Dwyer, D., Wood, J., Macartney, K., McIntyre, P. (2018). Australian rubella serosurvey 2012-2013: On track for elimination? Vaccine, 36(20), 2794-2798. [More Information]
  • Sheel, M., Beard, F., Quinn, H., Dey, A., Kirk, M., Koehler, A., Markey, P., McIntyre, P., Macartney, K. (2018). Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015. Communicable diseases intelligence (2018), 42, 1-27.
  • Gidding, H., Quinn, H., Hueston, L., Dwyer, D., McIntyre, P. (2018). Declining measles antibodies in the era of elimination: Australia's experience. Vaccine, 36(4), 507-513. [More Information]
  • Jayasinghe, S., Chiu, C., Quinn, H., Menzies, R., Gilmour, R., McIntyre, P. (2018). Effectiveness of 7- and 13-valent pneumococcal conjugate vaccines in a schedule without a booster dose: A 10-year observational study. Clinical Infectious Diseases, 67(3), 367-374. [More Information]
  • Gidding, H., McCallum, L., Fathima, P., Moore, H., Snelling, T., Blyth, C., Jayasinghe, S., Giele, C., de Klerk, N., Andrews, R., McIntyre, P. (2018). Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia. Vaccine, 36(19), 2650-2656. [More Information]
  • McIntyre, P., Edwards, K. (2018). Genetically modified pertussis toxin: a quantum leap? The Lancet Infectious Diseases, 18(11), 1169-1171. [More Information]
  • Wood, N., Nolan, T., Marshall, H., Richmond, P., Gibbs, E., Perrett, K., McIntyre, P. (2018). Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial. JAMA Pediatrics, 172(11), 1045-1052. [More Information]
  • Whittaker, E., Goldblatt, D., McIntyre, P., Levy, O. (2018). Neonatal immunization: Rationale, current state, and future prospects. Frontiers in Immunology, 9, 1-10. [More Information]
  • Dyda, A., McIntyre, P., Karki, S., MacIntyre, C., Newall, A., Banks, E., Kaldor, J., Liu, B. (2018). Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program. Vaccine, 36(29), 4157-4160. [More Information]
  • Chen, C., Beutels, P., Wood, J., Menzies, R., MacIntyre, C., McIntyre, P., Newall, A. (2018). Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine, 36(42), 6307-6313. [More Information]
  • Cheah, B., Davies, J., Singh, G., Wood, N., Jackson, K., Littlejohn, M., Davison, B., McIntyre, P., Locarnini, S., Davis, J., et al (2018). Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia. Vaccine, 36(24), 3533-3540. [More Information]
  • Chen, C., Wood, J., Beutels, P., Menzies, R., MaCintyre, C., Dirmesropian, S., Reyes, J., McIntyre, P., Newall, A. (2018). The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia. Vaccine, 36(10), 1265-1271. [More Information]
  • Phillips, A., Beard, F., Macartney, K., Chan, J., Gilmour, R., Saravanos, G., McIntyre, P. (2018). Vaccine-preventable child deaths in New South Wales from 2005 to 2014: How much is preventable? Journal of Paediatrics and Child Health, 54(4), 356-364. [More Information]
  • Reyes, J., Wood, J., Beutels, P., Macartney, K., McIntyre, P., Menzies, R., Mealing, N., Newall, A. (2017). Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine, 35(2), 345-352. [More Information]
  • Dirmesropian, S., Wood, J., MacIntyre, C., Beutels, P., McIntyre, P., Menzies, R., Reyes, J., Chen, C., Newall, A. (2017). Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians. Vaccine, 35(34), 4307-4314. [More Information]
  • Yin, K., Jayasinghe, S., Charles, P., King, C., Chiu, C., Menzies, R., McIntyre, P. (2017). Determining the contribution of Streptococcus pneumoniae to community-acquired pneumonia in Australia. Medical Journal of Australia, 207(9), 396-400. [More Information]
  • Archer, B., Chiu, C., Jayasinghe, S., Richmond, P., McVernon, J., Lahra, M., Andrews, R., McIntyre, P. (2017). Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: Priority populations for vaccination. Medical Journal of Australia, 207(9), 382-387. [More Information]
  • Macartney, K., Gidding, H., Trinh, L., Wang, H., Dey, A., Hull, B., Orr, K., McRae, J., Richmond, P., Gold, M., McIntyre, P., Wood, N., et al (2017). Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia. JAMA Pediatrics, 171(10), 992-998. [More Information]
  • Wiley, K., Regan, A., McIntyre, P. (2017). Immunisation and pregnancy - who, what, when and why? Australian Prescriber, 40(4), 122-124. [More Information]
  • Hull, B., Hendry, A., Dey, A., Beard, F., Brotherton, J., McIntyre, P. (2017). Immunisation coverage annual report, 2014. Communicable Diseases Intelligence, 41(1), E68-E90.
  • Trinh, L., Macartney, K., McIntyre, P., Chiu, C., Dey, A., Menzies, R. (2017). Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data. Vaccine, 35(11), 1524-1529. [More Information]
  • Jayasinghe, S., Menzies, R., Chiu, C., Toms, C., Blyth, C., Krause, V., McIntyre, P. (2017). Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014. Clinical Infectious Diseases, 64(2), 175-183. [More Information]
  • Beard, F., Leask, J., McIntyre, P. (2017). No jab, no pay and vaccine refusal in Australia: The jury is out. Medical Journal of Australia, 207(9), 407-407.e1. [More Information]
  • Beard, F., Leask, J., McIntyre, P. (2017). No jab, no pay and vaccine refusal in australia: The jury is out. Medical Journal of Australia, 206(9), 381-383. [More Information]
  • Pillsbury, A., Quinn, H., Evans, T., McIntyre, P., Brotherton, J. (2017). Population-level herd protection of males from a female human papillomavirus vaccination program: Evidence from australian serosurveillance. Clinical Infectious Diseases, 65(5), 827-832. [More Information]
  • Sheel, M., Beard, F., Dey, A., Macartney, K., McIntyre, P. (2017). Rates of hospitalisation for herpes zoster may warrant vaccinating indigenous Australians under 70. Medical Journal of Australia, 207(9), 395-396. [More Information]
  • Sobanjo-ter Meulen, A., Duclos, P., McIntyre, P., Lewis, K., Van Damme, P., O'Brien, K., Klugman, K. (2016). Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries. Clinical Infectious Diseases, 63(suppl 4), S123-S133. [More Information]
  • Li-Kim-Moy, J., Yin, K., Patel, C., Beard, F., Chiu, C., Macartney, K., McIntyre, P. (2016). Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015. Communicable Diseases Intelligence Quarterly Report, 40(4), E482-E495.
  • Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., Marshall, H., McIntyre, P., Lan, R. (2016). Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. Vaccine, 34(34), 3967-3971. [More Information]
  • Hale, S., Quinn, H., Kesson, A., Wood, N., McIntyre, P. (2016). Changing Patterns of Pertussis in a Children's Hospital in the Polymerase Chain Reaction Diagnostic Era. The Journal of Pediatrics, 170, 161-165.e1. [More Information]
  • Karki, S., Dyda, A., Newall, A., Heywood, A., Macintyre, C., McIntyre, P., Banks, E., Liu, B. (2016). Comparison of influenza vaccination coverage between immigrant and Australian-born adults. Vaccine, 34(50), 6388-6395. [More Information]
  • Safarchi, A., Octavia, S., Wu, S., Kaur, S., Sintchenko, V., Gilbert, G., Wood, N., McIntyre, P., Marshall, H., Keil, A., et al (2016). Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. Journal of Infection, 72(4), 468-477. [More Information]
  • Chow, M., Khandaker, G., McIntyre, P. (2016). Global Childhood Deaths From Pertussis: A Historical Review. Clinical Infectious Diseases, 63(suppl 4), S134-S141. [More Information]
  • Karki, S., Newall, A., MacIntyre, C., Heywood, A., McIntyre, P., Banks, E., Liu, B. (2016). Healthcare resource utilisation associated with herpes zoster in a prospective cohort of older Australian adults. PloS One, 11(8), 1-13. [More Information]
  • Hull, B., Dey, A., Beard, F., Menzies, R., Brotherton, J., McIntyre, P. (2016). Immunisation coverage annual report, 2013. Communicable Diseases Intelligence, 40(1), e146-e169.
  • Campbell, P., McVernon, J., McIntyre, P., Geard, N. (2016). Influence of Population Demography and Immunization History on the Impact of an Antenatal Pertussis Program. Clinical Infectious Diseases, 63(suppl 4), S213-S220. [More Information]
  • McIntyre, P., Forrest, J. (2016). Margaret Anne Burgess. Medical Journal of Australia, 204(10), 389-391. [More Information]
  • Lawrence, G., Wang, H., Lahra, M., Booy, R., McIntyre, P. (2016). Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme. Epidemiology and Infection, 144(11), 2382-2391. [More Information]
  • Snelling, T., McIntyre, P. (2016). Modeling the Effects of Priming With the Whole-Cell Bordetella Pertussis Vaccine. JAMA Pediatrics, 170(12), 1228-1229. [More Information]
  • Newall, A., Reyes, J., McIntyre, P., Menzies, R., Beutels, P., Wood, J. (2016). Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical. Vaccine, 34(3), 320-327. [More Information]
  • Dey, A., Knox, S., Wang, H., Beard, F., McIntyre, P. (2016). Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2008-2011. Communicable Diseases Intelligence, 40(Suppl), S1-S70.
  • Pillsbury, A., Chiew, M., Bag, S., Hope, K., Norton, S., Conaty, S., Sheppeard, V., McIntyre, P. (2016). The changing epidemiology of measles in an era of elimination: lessons from health-care-setting transmissions of measles during an outbreak in New South Wales, Australia, 2012. Western Pacific Surveillance and Response, 7(3), 1-10. [More Information]
  • Clarke, M., McIntyre, P., Blyth, C., Wood, N., Octavia, S., Sintchenko, V., Giles, L., Quinn, H., Hill, V., Hanly, G., et al (2016). The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. Journal of Infection, 72(2), 171-178. [More Information]
  • Holt, P., Snelling, T., White, O., Sly, P., de Klerk, N., Carapetis, J., van den Biggelaar, A., Wood, N., McIntyre, P., Gold, M. (2016). Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine? Vaccine, 34(35), 4257-4262. [More Information]
  • Beard, F., Hull, B., Leask, J., Dey, A., McIntyre, P. (2016). Trends and patterns in vaccination objection, Australia, 2002-2013. Medical Journal of Australia, 204(7), 275.e1-275.e6. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2016). Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: Analysis of national hospital data. BMC Infectious Diseases, 16(1), 1-11. [More Information]
  • Chiew, M., Dey, A., Martin, N., Wang, H., Davis, S., McIntyre, P. (2015). Australian vaccine preventable disease epidemiological review series: measles 2000-2011. Communicable Diseases Intelligence Quarterly Report, 39(1), e1-e9.
  • Gao, Z., Wood, J., Gidding, H., Newall, A., Menzies, R., Wang, H., McIntyre, P., MacIntyre, C. (2015). Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future. Epidemiology and Infection, 143(7), 1467-1476. [More Information]
  • Brouwer, M., McIntyre, P., Prasad, K., van der Beek, D. (2015). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 9, 1-108. [More Information]
  • Campbell, P., McCaw, J., McIntyre, P., McVernon, J. (2015). Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine, 33(43), 5794-5800. [More Information]
  • Wood, J., Goeyvaerts, N., MacIntyre, C., Menzies, R., McIntyre, P., Hens, N. (2015). Estimating vaccine coverage from serial trivariate serologic data in the presence of waning immunity. Epidemiology, 26(3), 381-389. [More Information]
  • Jayasinghe, S., Chiu, C., Menzies, R., Lehmann, D., Cook, H., Giele, C., Krause, V., McIntyre, P. (2015). Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children. Vaccine, 33(48), 6666-6674. [More Information]
  • Dyda, A., MacIntyre, C., McIntyre, P., Newall, A., Banks, E., Kaldor, J., Liu, B. (2015). Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program. Vaccine, 33(29), 3299-3305. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2015). Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data. The Journal of Infectious Diseases, 211(1), 91-99. [More Information]
  • Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., Gold, M., Kynaston, J., Blyth, C., Zurynski, Y., Elliott, E., Booy, R., McIntyre, P., Wood, N., et al (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417. [More Information]
  • Brotherton, J., Condon, J., McIntyre, P., Tabrizi, S., Malloy, M., Garland, S. (2015). Human papillomavirus prevalence to age 60 years among Australian women prevaccination. Sexual Health, 12(4), 353-359. [More Information]
  • Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., et al (2015). International collaboration to assess the risk of Guillain BarrĂ© Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. [More Information]
  • Lowbridge, C., McIntyre, P., Gilmour, R., Chiu, C., Seale, H., Ferson, M., Gilbert, G. (2015). Long term population impact of seven-valent pneumococcal conjugate vaccine with a "3+0" schedule-How do "2+1" and "3+1" schedules compare? Vaccine, 33(28), 3234-3241. [More Information]
  • Menzies, R., Bremner, K., Wang, H., Beard, F., McIntyre, P. (2015). Long-Term Trends in Invasive Haemophilus influenzae Type b Disease among Indigenous Australian Children Following use of PRP-OMP and PRP-T Vaccines. Pediatric Infectious Disease Journal, 34(6), 621-626. [More Information]
  • Dyda, A., MacIntyre, C., Banks, E., Kaldor, J., Newall, A., McIntyre, P., Liu, B. (2015). Medicare Benefits Schedule data to monitor influenza immunisation in Australian adults. Public Health Research and Practice, 25(4), 1-6. [More Information]
  • Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., Marshall, H., McIntyre, P., Lan, R. (2015). Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine, 33(46), 6277-6281. [More Information]
  • Leach, A., Mulholland, E., Santosham, M., Torzillo, P., Brown, N., McIntyre, P., Smith-Vaughan, H., Skull, S., Balloch, A., Andrews, R., et al (2015). Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk indigenous infants (PREV-IX-COMBO): Protocol of a randomised controlled trial. BMJ Open, 5(1), 1-10. [More Information]
  • Menzies, R., Jardine, A., McIntyre, P. (2015). Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination. Clinical Infectious Diseases, 61(6), 927-933. [More Information]
  • Woods, J., Heywood, A., Menzies, R., McIntyre, P., MacIntyre, C. (2015). Predicting localised measles outbreak potential in Australia. Vaccine, 33(9), 1176-1181. [More Information]
  • Marshall, H., Clarke, M., Rasiah, K., Richmond, P., Buttery, J., Reynolds, G., Andrews, R., Nissen, M., Wood, N., McIntyre, P. (2015). Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatric Infectious Disease Journal, 34(4), 339-345. [More Information]
  • Karki, S., Gidding, H., Newall, A., McIntyre, P., Liu, B. (2015). Risk factors and burden of acute Q fever in older adults in New South Wales: a prospective cohort study. Medical Journal of Australia, 203(11), 438.e1-438.e6. [More Information]
  • Liu, B., Heywood, A., Reekie, J., Banks, E., Kaldor, J., McIntyre, P., Newall, A., MacIntyre, C. (2015). Risk factors for herpes zoster in a large cohort of unvaccinated older adults: A prospective cohort study. Epidemiology and Infection, 143(13), 2871-2881. [More Information]
  • Karki, S., McIntyre, P., Newall, A., MacIntyre, C., Banks, E., Liu, B. (2015). Risk factors for pertussis hospitalizations in Australians aged 45 years and over: A population based nested case-control study. Vaccine, 33(42), 5647-5653. [More Information]
  • Gibson, A., Jorm, L., McIntyre, P. (2015). Using linked birth, notification, hospital and mortality data to examine false-positive meningococcal disease reporting and adjust disease incidence estimates for children in New South Wales, Australia. Epidemiology and Infection, 143(12), 2570-2579. [More Information]
  • MacIntyre, C., Ridda, I., Gao, Z., Moa, A., McIntyre, P., Sullivan, J., Jones, T., Hayen, A., Lindley, R. (2014). A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly. PloS One, 9(4), 1-14. [More Information]
  • Wood, N., Marshall, H., White, O., Holt, P., McIntyre, P. (2014). Antibody and cell-mediated immunity to pertussis 4 years after monovalent acellular pertussis vaccine at birth. Pediatric Infectious Disease Journal, 33(5), 511-517. [More Information]
  • Snelling, T., McIntyre, P. (2014). Assessing the effect of meningitis prevention and treatment. The Lancet Infectious Diseases, 14(9), 780-781. [More Information]
  • Pillsbury, A., Quinn, H., McIntyre, P. (2014). Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012. Communicable Diseases Intelligence Quarterly Report, 38(3), E179-194.
  • Khandaker, G., Zurynski, Y., Ridley, G., Buttery, J., Marshall, H., Richmond, P., Royle, J., Gold, M., Walls, T., Whitehead, B., McIntyre, P., Booy, R., Elliott, E., et al (2014). Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: A prospective national study. Influenza and Other Respiratory Viruses, 8(6), 636-645. [More Information]
  • Quinn, H., Snelling, T., Macartney, K., McIntyre, P. (2014). Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics, 133(3), e513-e519. [More Information]
  • Newall, A., Reyes, J., Wood, J., McIntyre, P., Menzies, R., Beutels, P. (2014). Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses. Vaccine, 32(7), 759-765. [More Information]
  • McCallum, L., Liu, B., McIntyre, P., Jorm, L. (2014). Estimating the burden of pertussis in young children on hospitals and emergency departments: a study using linked routinely collected data. Epidemiology and Infection, 142(4), 695-705. [More Information]
  • Chiew, M., Gidding, H., Dey, A., Wood, J., Martin, N., Davis, S., McIntyre, P. (2014). Estimating the measles effective reproduction number in Australia from routine notification data. Bulletin of the World Health Organization, 92(3), 171-177. [More Information]
  • Dey, A., Gidding, H., Menzies, R., McIntyre, P. (2014). General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events. Vaccine, 32(19), 2204-2208. [More Information]
  • Tabrizi, S., Brotherton, J., Stevens, M., Condon, J., McIntyre, P., Smith, D., Garland, S. (2014). HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. Journal Of Clinical Virology, 60(3), 250-256. [More Information]
  • Hull, B., Dey, A., Menzies, R., Brotherton, J., McIntyre, P. (2014). Immunisation coverage, 2012. Communicable Diseases Intelligence, 38(3), E208-E231.
  • Menzies, R., Krause, V., McIntyre, P. (2014). Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older: In Reply. Medical Journal of Australia, 201(4), 200.
  • Quinn, H., Wood, N., Cannings, K., Dey, A., Wang, H., Menzies, R., Moberley, S., Reid, S., McIntyre, P., Macartney, K. (2014). Intussusception after monovalent human rotavirus vaccine in Australia: Severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatric Infectious Disease Journal, 33(9), 959-965. [More Information]
  • Quinn, H., Snelling, T., Habig, A., Chiu, C., Spokes, P., McIntyre, P. (2014). Parental Tdap Boosters and Infant Pertussis: A Case-Control Study. Pediatrics, 134(4), 713-720. [More Information]
  • McIntyre, P., Nolan, T. (2014). Pertussis control: where to now? Improving protection against pertussis requires sorting the facts from the artefacts. Medical Journal of Australia, 200(6), 306-307. [More Information]
  • McIntyre, P., Clark, T. (2014). Pertussis vaccine in pregnancy-first dose for every infant. The Lancet, 384(9953), 1484-1486. [More Information]
  • Lam, C., Octavia, S., Ricafort, L., Sintchenko, V., Gilbert, G., Wood, N., McIntyre, P., Marshall, H., Guiso, N., Keil, A., et al (2014). Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerging Infectious Diseases, 20(4), 626-633. [More Information]
  • Macartney, K., Heywood, A., McIntyre, P. (2014). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 6, 1-45. [More Information]
  • Heywood, A., Wang, H., Macartney, K., McIntyre, P. (2014). Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bulletin of the World Health Organization, 92(8), 593-604. [More Information]
  • Ward, K., Quinn, H., Menzies, R., McIntyre, P. (2013). A history of adolescent school-based vaccination in Australia. Communicable Diseases Intelligence Quarterly Report, 37(2), E168-E174. [More Information]
  • Ward, K., Quinn, H., Bachelor, M., Bryant, V., Campbell-Lloyd, S., Newbound, A., Skully, M., Webby, R., McIntyre, P. (2013). Adolescent school-based vaccination in Australia. Communicable Diseases Intelligence Quarterly Report, 37(2), E156-E167. [More Information]
  • Hull, B., Dey, A., Menzies, R., McIntyre, P. (2013). Annual immunisation coverage report, 2010. Communicable Diseases Intelligence Quarterly Report, 37(1), E21-E39. [More Information]
  • Gunaratnam, P., Gilmour, R., Lowbridge, C., McIntyre, P. (2013). Bug Breakfast in the Bulletin: invasive pneumococcal disease. NSW Public Health Bulletin, 24(3), 142-142. [More Information]
  • Marshall, H., McIntyre, P., Richmond, P., Buttery, J., Royle, J., Gold, M., Wood, N., Elliott, E., Zurynski, Y., Toi, C., Dwyer, D., Booy, R. (2013). Changes in Patterns of Hospitalized Children with Varicella and of Associated Varicella Genotypes After Introduction of Varicella Vaccine in Australia. Pediatric Infectious Disease Journal, 32(5), 530-537. [More Information]
  • Brouwer, M., McIntyre, P., Prasad, K., van de Beek, D. (2013). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 6, 1-100. [More Information]
  • Hull, B., Menzies, R., Macartney, K., McIntyre, P. (2013). Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: The Australian experience. Vaccine, 31(15), 1964-1969. [More Information]
  • Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., Macartney, K., et al (2013). International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. [More Information]
  • Carlin, J., Macartney, K., Lee, K., Quinn, H., Buttery, J., Lopert, R., Bines, J., McIntyre, P. (2013). Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clinical Infectious Diseases, 57(10), 1427-1434. [More Information]
  • Gao, Z., Wood, J., Burgess, M., Menzies, R., McIntyre, P., MacIntyre, C. (2013). Models of strategies for control of rubella and congenital rubella syndrome-A 40 year experience from Australia. Vaccine, 31(4), 691-697. [More Information]
  • Menzies, R., Markey, P., Boyd, R., Koehler, A., McIntyre, P. (2013). No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children. International Journal of Circumpolar Health, 72(Supplement 1), 1-6. [More Information]
  • Zurynski, Y., McIntyre, P., Booy, R., Elliott, E. (2013). Paediatric Active Enhanced Disease Surveillance: A new surveillance system for Australia. Journal of Paediatrics and Child Health, 49(7), 588-594. [More Information]
  • Chiu, C., McIntyre, P. (2013). Pneumococcal vaccines: past, present and future. Australian Prescriber, 36(3), 88-93a. [More Information]
  • Feikin, D., Kagucia, E., Loo, J., Link-Gelles, R., Puhan, M., Cherian, T., Levine, O., Jayasinghe, S., McIntyre, P., Menzies, R., et al (2013). Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites. PLoS Medicine, 10(9), 1-28. [More Information]
  • Wiley, K., Zuo, Y., Macartney, K., McIntyre, P. (2013). Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy. Vaccine, 31(4), 618-625. [More Information]
  • McIntyre, P., Sintchenko, V. (2013). The "How" of Polymerase Chain Reaction Testing for Bordetella pertussis Depends on the "Why". Clinical Infectious Diseases, 56(3), 332-334. [More Information]
  • Song, N., Gao, Z., Wood, J., Hueston, L., Gilbert, G., MacIntyre, C., Quinn, H., Menzies, R., McIntyre, P. (2012). Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination. Vaccine, 30(27), 4073-4078. [More Information]
  • McIntyre, P., O'Brien, K., Greenwood, B., van de Beek, D. (2012). Effect of vaccines on bacterial meningitis worldwide. The Lancet, 380(9854), 1703-1711. [More Information]
  • Campbell, P., McIntyre, P., Quinn, H., Hueston, L., Gilbert, G., McVernon, J. (2012). Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in Australia. PloS One, 7(4), 1-7. [More Information]
  • Wood, N., Sheppeard, V., Cashman, P., Palasanthiran, P., Casacelli, M., Cannings, K., McIntyre, P. (2012). Influenza Vaccine Safety in Children Less Than 5 Years Old. The 2010 and 2011 Experience in Australia. Pediatric Infectious Disease Journal, 31(2), 199-202. [More Information]
  • Hull, B., Dey, A., Campbell-Lloyd, S., Menzies, R., McIntyre, P. (2012). NSW Annual Immunisation Coverage Report, 2011. NSW Public Health Bulletin, 23(9-10), 179-186. [More Information]
  • Liu, B., McIntyre, P., Kaldor, J., Quinn, H., Ridda, I., Banks, E. (2012). Pertussis in Older Adults: Prospective Study of Risk Factors and Morbidity. Clinical Infectious Diseases, 55(11), 1450-1456. [More Information]
  • Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2012). Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011. Communicable Diseases Intelligence Quarterly Report, 36(1), 114-119. [More Information]
  • Halperin, S., Bettinger, J., Greenwood, B., Harrison, L., Jelfs, J., Ladhani, S., McIntyre, P., Ramsay, M., Safadi, M. (2012). The changing and dynamic epidemiology of meningococcal disease. Vaccine, 30S(Suppl 2), B26-B36. [More Information]
  • Liu, B., Guthridge, S., Li, S., Markey, P., Krause, V., McIntyre, P., Sullivan, E., Ward, J., Wood, N., Kaldor, J. (2012). The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on. Vaccine, 30(50), 7309-7314. [More Information]
  • Ridda, I., Yin, K., King, C., MacIntyre, R., McIntyre, P. (2012). The importance of pertussis in older adults: A growing case for reviewing vaccination strategy in the elderly. Vaccine, 30(48), 6745-6752. [More Information]
  • Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2011). Annual report: surveillance of adverse events following immunisation in Australia, 2010. Communicable Diseases Intelligence Quarterly Report, 35(4), 263-280. [More Information]
  • Gunasekera, H., Purcell, A., Eades, S., Banks, E., Wutzke, S., McIntyre, P., Redman, S., Woolfenden, S., Fernando, D., Craig, J. (2011). Healthy kids, health future: Ear health, speech and language among urban aboriginal children (the SEARCH study). Journal of Paediatrics and Child Health, 47(Suppl. 2), 6-6.
  • Garland, S., Brotherton, J., Condon, J., McIntyre, P., Stevens, M., David, S., Tabrizi, S. (2011). Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Medicine, 9(104), 1-13. [More Information]
  • Hull, B., Dey, A., Mahajan, D., Menzies, R., McIntyre, P. (2011). Immunisation coverage annual report, 2009. Communicable Diseases Intelligence Quarterly Report, 35(2), 132-148. [More Information]
  • Van Damme, P., McIntyre, P., Grimprel, E., Kuriyakose, S., Jacquet, J., Hardt, K., Messier, M., Van Der Meeren, O. (2011). Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix) in adults 55 years of age and over: a sub-analysis of four trials. Vaccine, 29, 5932-5939. [More Information]
  • Helms, C., Leask, J., Cooper, S., Chow, M., McIntyre, P. (2011). Implementation of mandatory immunisation of healthcare workers: Observations from New South Wales, Australia. Vaccine, 29(16), 2895-2901. [More Information]
  • Buttery, J., Danchin, M., Lee, K., Carlin, J., McIntyre, P., Elliott, E., Booy, R., Bines, J. (2011). Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia. Vaccine, 29(16), 3061-3066. [More Information]
  • Hull, B., Dey, A., Campbell-Lloyd, S., Menzies, R., McIntyre, P. (2011). NSW Annual Immunisation Coverage Report, 2010. NSW Public Health Bulletin, 22(9-10), 179-195. [More Information]
  • Quinn, P., Gold, M., Royle, J., Buttery, J., Richmond, P., McIntyre, P., Wood, N., Lee, S., Marshall, H. (2011). Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine, 29(25), 4230-4237. [More Information]
  • Foxwell, A., McIntyre, P., Quinn, H., Roper, K., Clements, M. (2011). Severe Pertussis in Infants: Estimated Impact of First Vaccine Dose at 6 Versus 8 Weeks in Australia. Pediatric Infectious Disease Journal, 30(2), 161-163. [More Information]
  • Mahajan, D., Menzies, R., Cook, J., Macartney, K., McIntyre, P. (2011). Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010. Communicable Diseases Intelligence Quarterly Report, 35(1), 21-28. [More Information]
  • Quinn, H., McIntyre, P. (2011). The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia. Bulletin of the World Health Organization, 89(9), 666-674. [More Information]
  • Quinn, H., Mahajan, D., Hueston, L., Campbell, P., Menzies, R., Gilbert, G., McIntyre, P. (2011). The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules. NSW Public Health Bulletin, 22(11-12), 224-229. [More Information]
  • Wood, N., McIntyre, P. (2010). 1st International Neonatal and Maternal Immunization Symposium. Expert Review of Obstetrics and Gynecology, 5(5), 507-509.
  • Wood, N., McIntyre, P., Marshall, H., Roberton, D. (2010). Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age. Pediatric Infectious Disease Journal, 29(3), 209-215. [More Information]
  • McIntyre, P. (2010). Adjunctive dexamethasone in meningitis: does value depend on clinical setting? The Lancet Neurology, 9(3), 229-231. [More Information]
  • Jardine, A., Deeks, S., Patel, M., Menzies, R., Gilbert, G., McIntyre, P. (2010). An evaluation of the Australian National Serosurveillance Program. Communicable Diseases Intelligence Quarterly Report, 34(1), 29-36. [More Information]
  • Mahajan, D., Roomiani, I., Gold, M., Lawrence, G., McIntyre, P., Menzies, R. (2010). Annual report: surveillance of adverse events following immunisation in Australia, 2009. Communicable Diseases Intelligence Quarterly Report, 34(3), 259-276. [More Information]
  • Burgess, M., McIntyre, P., Hellard, M., Ruff, T., Lefevre, I., Bock, H. (2010). Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Vaccine, 28(10), 2222-2226. [More Information]
  • Brouwer, M., McIntyre, P., de Gans, J., Prasad, K., van de Beek, D. (2010). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 1(9), 1-122. [More Information]
  • Wood, N., McIntyre, P. (2010). Epiglottitis: Going, going, but not gone yet. Journal of Paediatrics and Child Health, 46, 446. [More Information]
  • Ladhani, S., Heath, P., Slack, M., McIntyre, P., Diez-Domingo, J., Campos, J., Dagan, R., Ramsay, M., European Union Invasive Bacterial Infections Surveillance (EU-IBIS) Network, -. (2010). Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clinical Microbiology and Infection, 16(7), 948-954. [More Information]
  • Brotherton, J., Kaldor, J., McIntyre, P. (2010). HPV related surveillance activities in Australia. Vaccine, 28(47), 7453-7454. [More Information]
  • Gold, M., Buttery, J., McIntyre, P. (2010). Human Papillomavirus Vaccine Safety in Australia: Experience to Date and Issues for Surveillance. Sexual Health, 7(3), 320-324. [More Information]
  • Hull, B., Mahajan, D., Dey, A., Menzies, R., McIntyre, P. (2010). Immunisation coverage annual report, 2008. Communicable Diseases Intelligence Quarterly Report, 34(3), 241-258. [More Information]
  • Ridda, I., MacIntyre, C., Lindley, R., McIntyre, P., Brown, M., Oftadeh, S., Sullivan, J., Gilbert, G. (2010). Lack of pneumococcal carriage in the hospitalised elderly. Vaccine, 28(23), 3902-3904. [More Information]
  • Leask, J., Helms, C., Chow, M., Cooper, S., McIntyre, P. (2010). Making influenza vaccination mandatory for health care workers: the views of NSW Health administrators and clinical leaders. NSW Public Health Bulletin, 21(9-10), 243-247. [More Information]
  • Leask, J., Booy, R., McIntyre, P. (2010). MMR, Wakefield and The Lancet: what can we learn? Medical Journal of Australia, 193(1), 5-7. [More Information]
  • Hull, B., Dey, A., Mahajan, D., Campbell-Lloyd, S., Menzies, R., McIntyre, P. (2010). NSW Annual Immunisation Coverage Report, 2009. NSW Public Health Bulletin, 21, 210-223. [More Information]
  • Marshall, H., McIntyre, P., Roberton, D., Dinan, L., Hardt, K. (2010). Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. International Journal of Infectious Diseases, 14(1), E41-E49. [More Information]
  • Isaacs, D., Macartney, K., McIntyre, P. (2010). Rapid Response: Benefits and risks of childhood influenza vaccination. BMJ, , 1.
  • Jardine, A., Menzies, R., McIntyre, P. (2010). Reduction in Hospitalizations for Pneumonia Associated with the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia. Pediatric Infectious Disease Journal, 29(7), 607-612. [More Information]
  • Gunasekera, H., Knox, S., Morris, P., Britt, H., McIntyre, P., Craig, J. (2010). Spectrum and management of otitis media in Australian indigenous and non-indigenous children: a national study. Pediatrics, 121(S2), S128-S128.
  • White, O., Rowe, J., Richmond, P., Marshall, H., McIntyre, P., Wood, N., Holt, P. (2010). Th2-polarisation of Cellular Immune Memory to Neonatal Pertussis Vaccination. Vaccine, 28(14), 2648-2652. [More Information]
  • McIntyre, P., Durrheim, D., Campbell-Lloyd, S. (2010). The NSW Immunisation Strategy 2008-2011: how are we doing? NSW Public Health Bulletin, 21, 193-195. [More Information]
  • Quinn, H., McIntyre, P., Backhouse, J., Gidding, H., Brotherton, J., Gilbert, L. (2010). The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiology and Infection, 138(3), 426-433. [More Information]
  • Chiu, C., Dey, A., Wang, H., Menzies, R., Deeks, S., Mahajan, D., Macartney, K., Jardine, A., Quinn, H., Jelfs, J., Booy, R., Lawrence, G., Wood, N., McIntyre, P., et al (2010). Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence Quarterly Report, 34, S1-167. [More Information]
  • Menzies, R., Mahajan, D., Gold, M., Roomiani, I., McIntyre, P., Lawrence, G. (2009). Annual report: surveillance of adverse events following immunisation in Australia, 2008. Communicable Diseases Intelligence Quarterly Report, 33(4), 365-381. [More Information]
  • Gidding, H., Wallace, C., Lawrence, G., McIntyre, P. (2009). Australia's national Q fever vaccination program. Vaccine, 27(14), 2037-2041. [More Information]
  • McIntyre, P., Burgess, M., Egan, A., Schuerman, L., Hoet, B. (2009). Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination. Vaccine, 27(7), 1062-1066. [More Information]
  • Heywood, A., Gidding, H., Riddell, M., McIntyre, P., Macintyre, C., Kelly, H. (2009). Elimination of endemic measles transmission in Australia. Bulletin of the World Health Organization, 87(1), 64-71. [More Information]
  • Hull, B., Deeks, S., Menzies, R., McIntyre, P. (2009). Immunisation coverage annual report, 2007. Communicable Diseases Intelligence Quarterly Report, 33(2), 170-187. [More Information]
  • Ridda, I., MacIntyre, C., Lindley, R., Gao, Z., Sullivan, J., Yuan, F., McIntyre, P. (2009). Immunological responses to pneumococcal vaccine in frail older people. Vaccine, 27(10), 1628-1636. [More Information]
  • Gunasekera, H., Morris, P., McIntyre, P., Craig, J. (2009). Management of children with otitis media: a summary of evidence from recent systematic reviews. Journal of Paediatrics and Child Health, 45(10), 554-562. [More Information]
  • Simpkins, D., Wood, N., McIntyre, P., Menzies, R., Booy, R. (2009). Modern trends in mortality from meningococcal disease in Australia. Pediatric Infectious Disease Journal, 28(12), 1119-1120. [More Information]
  • McIntyre, P., Brotherton, J., Burgess, M. (2009). More data from Australia on sensitivity to HPV vaccine. BMJ, 338, b26. [More Information]
  • McIntyre, P., Wood, N. (2009). Pertussis in early infancy: disease burden and preventive strategies. Current Opinion in Infectious Diseases, 22(3), 215-223. [More Information]
  • Rank, C., Quinn, H., McIntyre, P. (2009). Pertussis Vaccine Effectiveness After Mass Immunization of High School Students in Australia. Pediatric Infectious Disease Journal, 28(2), 152-153. [More Information]
  • Wood, J., Gidding, H., Heywood, A., Macartney, K., McIntyre, P., MacIntyre, C. (2009). Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine, 27(2), 313-318. [More Information]
  • Hull, B., Deeks, S., McIntyre, P. (2009). The Australian Childhood Immunisation Register-A model for universal immunisation registers? Vaccine, 27(37), 5054-5060. [More Information]
  • Jardine, A., Menzies, R., Deeks, S., Patel, M., McIntyre, P. (2009). The Impact of Pneumococcal Conjugate Vaccine on Rates of Myringotomy With Ventilation Tube Insertion in Australia. Pediatric Infectious Disease Journal, 28(9), 761-765. [More Information]
  • Leask, J., McIntyre, P. (2009). Vaccine refusal and the risks of vaccine-preventable diseases. New England Journal of Medicine, 361(7), 723. [More Information]
  • Brotherton, J., Kemp, A., McIntyre, P., Burgess, M., Gold, M., Campbell-Lloyd, S. (2008). Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ, 179(6), 525-533. [More Information]
  • Lawrence, G., Gold, M., Hill, R., Deeks, S., Glasswell, A., McIntyre, P. (2008). Annual report: surveillance of adverse events following immunisation in Australia, 2007. Communicable Diseases Intelligence Quarterly Report, 32(4), 371-87. [More Information]
  • Begg, K., Roche, P., Owen, R., Liu, C., Kaczmarek, M., McIntyre, P., Menzies, R., East, I., Coleman, D., O'Neill, K., et al (2008). Australia's notifiable diseases status, 2006, Annual Report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence Quarterly Report, 32, 139-207.
  • Yuan, F., Marks, K., Wong, M., Watson, S., de Leon, E., McIntyre, P., Sullivan, J. (2008). Clinical relevance of TLR2, TLR4, CD14 and FccRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunology and Cell Biology, 86, 268-270. [More Information]
  • Ridda, I., Lindley, R., McIntyre, P., MacIntyre, C., Gao, Z. (2008). Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine, 26(44), 5633-5640. [More Information]
  • Wood, N., Warlow, M., Quinn, H., Selvey, C., Lum, G., McIntyre, P., Kaldor, J. (2008). Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia. Australian and New Zealand Journal of Public Health, 32(3), 272-275. [More Information]
  • Ridda, I., Motbey, C., Lam, L., Lindley, R., McIntyre, P., MacIntyre, C. (2008). Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge. Vaccine, 26(2), 234-240. [More Information]
  • McIntyre, P., Leask, J. (2008). Improving uptake of MMR vaccine. British Medical Journal, 336(7647), 729-730. [More Information]
  • Wood, N., Quinn, H., McIntyre, P., Elliott, E. (2008). Pertussis in infants: preventing deaths and hospitalisations in the very young. Journal of Paediatrics and Child Health, 44(4), 161-165. [More Information]
  • Wood, N., McIntyre, P. (2008). Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatric Respiratory Reviews, 9(3), 201-11; quiz 211-2. [More Information]
  • Newall, A., Brotherton, J., Quinn, H., McIntyre, P., Backhouse, J., Gilbert, L., Esser, M., Erick, J., Bryan, J., Formica, N., MacIntyre, C. (2008). Population Seroprevalence of Human Papillo-mavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia. Clinical Infectious Diseases, 46(11), 1647-1655. [More Information]
  • Aratchige, P., McIntyre, P., Quinn, H., Gilbert, G. (2008). Recent increases in mumps incidence in Australia: the "forgotten" age group in the 1998 Australian Measles Control Campaign. Medical Journal of Australia, 189(8), 434-437. [More Information]
  • Ward, K., McIntyre, P., Kirkwood, C., Roche, P., Ferson, M., Van Buynder, P., Roberts-Witteveen, A., Kesson, A., Krause, V. (2008). Rotavirus surveillance in Australia. Communicable Diseases Intelligence Quarterly Report, 32(1), 82-87. [More Information]
  • Cagney, M., McIntyre, P., Heron, L., Giammanco, A., MacIntyre, C. (2008). The relationship between pertussis symptomatology, incidence and serology in adolescents. Vaccine, 26(44), 5547-5553. [More Information]
  • Wang, H., Deeks, S., Glasswell, A., McIntyre, P. (2008). Trends in invasive haemophilus influenzae type B disease in Australia, 1995-2005. Communicable Diseases Intelligence Quarterly Report, 32(3), 316-25. [More Information]
  • Ridley, G., Menzies, R., McIntyre, P. (2008). Update on childhood pneumococcal vaccination. Pediatric Health, 2(3), 351-365.
  • Menzies, R., Turnour, C., Chiu, C., McIntyre, P. (2008). Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 2003 to 2006. Communicable Diseases Intelligence Quarterly Report, 32(Supplement), S2-S67. [More Information]
  • Macartney, K., McIntyre, P. (2008). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 2008 (3), CD001833-1-CD001833-27. [More Information]
  • Hull, B., Deeks, S., Menzies, R., McIntyre, P. (2008). What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children? A 2007 update. Communicable Diseases Intelligence Quarterly Report, 32(2), 257-60. [More Information]
  • Lawrence, G., Aratchige, P., Boyd, I., McIntyre, P., Gold, M. (2007). Annual report on surveillance of adverse events following immunisation in Australia, 2006. Communicable Diseases Intelligence Quarterly Report, 31(3), 269-282. [More Information]
  • Owen, R., Roche, P., Hope, K., Yohannes, K., Roberts, A., Liu, C., Stirzaker, S., Kong, F., Bartlett, M., Donovan, B., McIntyre, P., et al (2007). Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence Quarterly Report, 31(1), 1-70. [More Information]
  • Hull, B., McIntyre, P. (2007). Compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia. Communicable Diseases Intelligence Quarterly Report, 31, 198-202. [More Information]
  • van de Beek, D., de Gans, J., McIntyre, P., Prasad, K. (2007). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 1(Art. No.: CD004405), DOI: 10.1002/14651858.CD004405.pub2. [More Information]
  • Macartney, K., MacIntyre, C., McIntyre, P. (2007). Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006. Communicable Diseases Intelligence Quarterly Report, 31(3), 303-310. [More Information]
  • MacIntyre, C., Burgess, M., Isaacs, D., McIntyre, P., Menzies, R., Hull, B. (2007). Epidemiology of severe hepatitis A in Indigenous Australian children. Journal of Paediatrics and Child Health, 43(5), 383-387. [More Information]
  • Quinn, H., McIntyre, P. (2007). Pertussis epidemiology in Australia over the decade 1995-2005: trends by region and age group. Communicable Diseases Intelligence Quarterly Report, 31(2), 205-215. [More Information]
  • Elliott, E., McIntyre, P., Wood, N. (2007). Pertussis in infancy: a review of strategies for prevention. SII Csalud, , 0-0.
  • Ridda, I., MacIntyre, C., Lindley, R., McIntyre, P., Sullivan, J., Gilbert, G., Kovoor, P., Manolios, N., Fox, J. (2007). Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Human Vaccines, 3(3), 57-60. [More Information]
  • Gidding, H., Wood, J., MacIntyre, C., Kelly, H., Lambert, S., Gilbert, G., McIntyre, P. (2007). Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine, 25(18), 3574-3580. [More Information]
  • Gidding, H., Warlow, M., MacIntyre, C., Backhouse, J., Gilbert, L., Quinn, H., McIntyre, P. (2007). The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine, 25(51), 8637-8641. [More Information]
  • Gunasekera, H., Knox, S., Morris, P., Britt, H., McIntyre, P., Craig, J. (2007). The spectrum and management of otitis media in Australian Indigenous and non-Indigenous children: a national study. Pediatric Infectious Disease Journal, 26(8), 689-692. [More Information]
  • Brotherton, J., Wang, H., Schaffer, A., Quinn, H., Menzies, R., Hull, B., Lawrence, C., Wood, J., Wood, N., Rosewell, A., Newall, A., Macartney, K., Gidding, H., McIntyre, P., Booy, R., et al (2007). Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report, 31(Suppl June 2007), 1-152. [More Information]
  • Menzies, R., McIntyre, P., Reid, R., O'Brien, K., Santosham, M., Watt, J., Moberley, S., Stirling, J., Gooda, M., Green, M., et al (2007). Vaccine preventable diseases in indigenous populations-International perspectives Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia. Vaccine, 25, 7281-4. [More Information]
  • Lawrence, G., Boyd, I., McIntyre, P., Isaacs, D. (2006). Annual report: Surveillance of adverse events following immunisation in Australia, 2005. Communicable Diseases Intelligence Quarterly Report, 30(3), 319-333. [More Information]
  • Gubbay, J., McIntyre, P., Gilmour, R. (2006). Cellulitis in childhood invasive pneumococcal disease: a population-based study. Journal of Paediatrics and Child Health, 42(6), 354-358. [More Information]
  • Backhouse, J., Gidding, H., McIntyre, P., Gilbert, G. (2006). Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clinical and Vaccine Immunology, 13(7), 764-767. [More Information]
  • Kolos, V., Menzies, R., McIntyre, P. (2006). Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination. Vaccine, 25, 588-590. [More Information]
  • Beard, F., McIntyre, P., Gidding, H., Watson, M. (2006). Influenza related hospitalisations in Sydney, New South Wales, Australia. Archives of Disease in Childhood, 91(1), 20-25. [More Information]
  • Backhouse, J., Gidding, H., MacIntyre, C., McIntyre, P., Gilbert, G. (2006). Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia. Vaccine, 25(7), 1310-1315. [More Information]
  • McIntyre, P., Quinn, H. (2006). Tetanus in the elderly-An important preventable disease in Australia. Vaccine, 25(7), 1304-1309. [More Information]
  • Watson, M., Gilmour, R., Menzies, R., Ferson, M., McIntyre, P., New South Wales, P. (2006). The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clinical Infectious Diseases, 42(2), 211-215. [More Information]
  • Cagney, M., MacIntyre, C., McIntyre, P., Giammanco, A., PUECH, M. (2006). The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiology and Infection, 134(6), 1208-1216. [More Information]
  • Hull, B., McIntyre, P. (2006). Timeliness of childhood immunisation in Australia. Vaccine, 24(20), 4403-4408. [More Information]
  • Wood, N., McIntyre, P., Wong, M. (2006). Vaccination for the paediatrician. Journal of Paediatrics and Child Health, 42, 665-673. [More Information]
  • Menzies, R., McIntyre, P. (2006). Vaccine Preventable Diseases and Vaccination Policy for Indigenous Populations. Epidemiologic Reviews, 28, 71-80. [More Information]
  • Clements, C., McIntyre, P. (2006). When science is not enough - a risk/benefit profile of thiomersal-containing vaccines. Expert Opinion on Drug Safety, 5(1), 17-29. [More Information]
  • Horby, P., MacIntyre, C., McIntyre, P., Gilbert, G., Staff, M., Hanlon, M., Heron, L., Cagney, M., Bennett, C. (2005). A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiology and Infection, 133(2), 229-236. [More Information]
  • McIntyre, P., MacIntyre, C., Gilmour, R., Wang, H. (2005). A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Archives of Disease in Childhood, 90(4), 391-396. [More Information]
  • Lawrence, G., Boyd, I., McIntyre, P., Isaacs, D. (2005). Annual report: surveillance of adverse events following immunisation in Australia, 2004. Communicable Diseases Intelligence Quarterly Report, 29(3), 248-62. [More Information]
  • Cagney, M., MacIntyre, C., McIntyre, P., Peat, J. (2005). Childhood asthma diagnosis and use of asthma medication. Australian Family Physician, 34(3), 193-196. [More Information]
  • Cagney, M., MacIntyre, C., McIntyre, P., Torvaldsen, S., Melot, V. (2005). Cough symptoms in children aged 5-14 years in Sydney, Australia: non-specific cough or unrecognized pertussis? Respirology, 10(3), 359-364. [More Information]
  • Wood, N., Menzies, R., McIntyre, P. (2005). Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease. Internal Medicine Journal, 35(9), 530-535. [More Information]
  • Wood, N., Backhouse, J., Gidding, H., Gilbert, G., Lum, G., McIntyre, P. (2005). Estimates of chronic hepatitis B virus infection in the Northern Territory. Communicable Diseases Intelligence Quarterly Report, 29(3), 289-290. [More Information]
  • McIntyre, P., Kelly, H., Mulholland, E. (2005). Immunisation at the crossroads: 9th National Immunisation/1st Asia-Pacific Vaccine Preventable Diseases Conference. Medical Journal of Australia, 182(1), 15-16. [More Information]
  • McIntyre, P. (2005). Immunisation: reducing health inequality for Indigenous Australians. Medical Journal of Australia, 182(5), 207-8. [More Information]
  • Andrews, R., Skull, S., Byrnes, G., Campbell, D., Turner, J., McIntyre, P., Kelly, H. (2005). Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria. Communicable Diseases Intelligence Quarterly Report, 29(3), 283-288. [More Information]
  • Isaacs, D., McIntyre, P. (2005). Influenza vaccines in healthy children. The Lancet, 365(9477), 2086-2086. [More Information]
  • McIntyre, P. (2005). Should dexamethasone be part of routine therapy of bacterial meningitis in industrialised countries? Advances in Experimental Medicine and Biology, 568, 189-197. [More Information]
  • Macartney, K., McIntyre, P. (2005). Universal varicella vaccination. Comment. Medical Journal of Australia, 183(5), 278-9. [More Information]
  • Gilbert, G., Gidding, H., Backhouse, J., McIntyre, P. (2005). Varicella seroprevalence and vaccine uptake in preschool children. Medical Journal of Australia, 182(1), 42-42.
  • Gilbert, G., Gidding, H., Backhouse, J., McIntyre, P. (2005). Varicella seroprevalence and vaccine uptake in preschool children. Medical Journal of Australia, 182(1), 42. [More Information]
  • Macartney, K., Beutels, P., McIntyre, P., Burgess, M. (2005). Varicella vaccination in Australia. Journal of Paediatrics and Child Health, 41(11), 544-552. [More Information]
  • Leask, J., Williams, A., McIntyre, P., O'Dea, D. (2004). Are General Practice Registrars Prepared For Immunisation? A Cross Sectional Survey. Australian Family Physician, 33(8), 665-667.
  • Andrews, R., Counahan, M., Hogg, G., McIntyre, P. (2004). Effectiveness Of A Publicly Funded Pneumococcal Vaccination Program Against Invasive Pneumococcal Disease Among The Elderly In Victoria, Australia. Vaccine, 23(2), 132-138. [More Information]
  • Lawrence, G., MacIntyre, C., McIntyre, P., Hull, B. (2004). Effectiveness Of The Linkage Of Child Care And Maternity Payments To Childhood Immunisation. Vaccine, 22(17-18), 2345-2350. [More Information]
  • Hull, B., McIntyre, P., Couzos, S. (2004). Evaluation Of Immunisation Coverage For Aboriginal And Torres Strait Islander Children Using The Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health, 28(1), 47-52. [More Information]
  • McIntyre, P., Turnbull, F., Egan, A., Burgess, M., Wolter, J., Schuerman, L. (2004). High Levels Of Antibody In Adults Three Years After Vaccination With A Reduced Antigen Content Diphtheria-Tetanus-Acellular Pertussis Vaccine. Vaccine, 23(2), 380-5. [More Information]
  • Elliott, E., McIntyre, P., Ridley, G., Morris, A., Massie, J., McEniery, J., Knight, G. (2004). National Study Of Infants Hospitalized With Pertussis In The Acellular Vaccine Era. Pediatric Infectious Disease Journal, 23(3), 246-252. [More Information]
  • Scuffham, P., McIntyre, P. (2004). Pertussis Vaccination Strategies For Neonates--An Exploratory Cost-Effectiveness Analysis. Vaccine, 22(21-22), 2953-2964. [More Information]
  • Belshe, R., Newman, F., Tsai, T., Karron, R., Reisinger, K., Roberton, D., Marshall, H., Schwartz, R., King, J., et al, McIntyre, P. (2004). Phase 2 Evaluation Of Parainfluenza Type 3 Cold Passage Mutant 45 Live Attenuated Vaccine In Healthy Children 6-18 Months Old. The Journal of Infectious Diseases, 189(3), 462-470. [More Information]
  • Brotherton, J., McIntyre, P. (2004). Planning for human papillomavirus vaccines in Australia: Report of a research group meeting. Communicable Diseases Intelligence Quarterly Report, 28(2), 249-254.
  • Lawrence, G., Hull, B., MacIntyre, C., McIntyre, P. (2004). Reasons For Incomplete Immunisation Among Australian Children. A National Survey Of Parents. Australian Family Physician, 33(7), 568-571.
  • van de Beek, D., de Gans, J., McIntyre, P., Prasad, K. (2004). Steroids In Adults With Acute Bacterial Meningitis: A Systematic Review. The Lancet Infectious Diseases, 4(3), 139-143. [More Information]
  • Lawrence, G., Boyd, I., McIntyre, P., Isaacs, D. (2004). Surveillance Of Adverse Events Following Immunisation: Australia 2002 To 2003. Communicable Diseases Intelligence Quarterly Report, 28(3), 324-338.
  • Poynten, M., McIntyre, P., Mooi, F., Heuvelman, K., Gilbert, G. (2004). Temporal Trends In Circulating Bordetella Pertussis Strains In Australia. Epidemiology and Infection, 132(2), 185-193. [More Information]
  • Butler, J., McIntyre, P., MacIntyre, C., Gilmour, R., Howarth, A., Sander, B. (2004). The Cost-Effectiveness Of Pneumococcal Conjugate Vaccination In Australia. Vaccine, 22(9-10), 1138-1149. [More Information]
  • Hethcote, H., Horby, P., McIntyre, P. (2004). Using Computer Simulations To Compare Pertussis Vaccination Strategies In Australia. Vaccine, 22(17-18), 2181-2191. [More Information]
  • Menzies, R., McIntyre, P., Beard, F. (2004). Vaccine Preventable Diseases And Vaccination Coverage In Aboriginal And Torres Strait Islander People, Australia, 1999 To 2002. Communicable Diseases Intelligence Quarterly Report, 28(2), 127-159.
  • Brotherton, J., McIntyre, P., PUECH, M., Wang, H., Gidding, H., Hull, B., Lawrence, G., MacIntyre, C., Wood, N., Armstrong, D. (2004). Vaccine Preventable Diseases And Vaccination Coverage In Australia 2001 To 2002. Communicable Diseases Intelligence Quarterly Report, 28(Supplement 2), vii-S116.
  • McIntyre, P. (2004). Vaccines for other neonatal infections: vaccination strategies for the prevention of neonatal pertussis. Expert Review of Vaccines, 3(4), 375-378. [More Information]
  • Hull, B., McIntyre, P. (2004). What Do We Know About 7Vpcv Coverage In Aboriginal And Torres Strait Islander Children? Communicable Diseases Intelligence Quarterly Report, 28(2), 238-243.
  • MacIntyre, C., McIntyre, P., Cagney, M. (2003). Community-based estimates of incidence and risk factors for childhood pneumonia in Western Sydney. Epidemiology and Infection, 131(3), 1091-1096. [More Information]
  • van de Beek, D., de Gans, J., McIntyre, P., Prasad, K. (2003). Corticosteroids in acute bacterial meningitis. Cochrane Database of Systematic Reviews, 24(1), 1-27. [More Information]
  • Bonacruz-Kazzi, G., McIntyre, P., Hanlon, M., Menzies, R. (2003). Diagnostic testing and discharge coding for whooping cough in a children's hospital. Journal of Paediatrics and Child Health, 39(8), 586-590. [More Information]
  • Torvaldsen, S., McIntyre, P. (2003). Do variations in pertussis notifications reflect incidence or surveillance practices? A comparison of infant notification rates and hospitalisation data in NSW. NSW Public Health Bulletin, 14(4-5), 81-84.
  • Torvaldsen, S., McIntyre, P. (2003). Effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatric Infectious Disease Journal, 22(11), 956-959. [More Information]
  • Torvaldsen, S., Simpson, J., McIntyre, P. (2003). Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998. European Journal Of Epidemiology, 18(1), 63-69. [More Information]
  • Hull, B., Lawrence, G., MacIntyre, C., McIntyre, P. (2003). Estimating immunisation coverage: is the 'third dose assumption' still valid? Communicable Diseases Intelligence Quarterly Report, 27(3), 357-361.
  • MacIntyre, C., Burgess, M., Hull, B., McIntyre, P. (2003). Hepatitis A vaccination options for Australia. Journal of Paediatrics and Child Health, 39(2), 83-87. [More Information]
  • Hull, B., Lawrence, G., MacIntyre, C., McIntyre, P. (2003). Immunisation coverage in Australia corrected for under-reporting to the Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health, 27(5), 533-538. [More Information]
  • Hull, B., Lawrence, G., MacIntyre, C., McIntyre, P. (2003). Is low immunisation coverage in inner urban areas of Australia due to low uptake or poor notification? Australian Family Physician, 32(12), 1041-1043.
  • Lawrence, G., MacIntyre, C., Hull, B., McIntyre, P. (2003). Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia. Australian and New Zealand Journal of Public Health, 27(4), 413-418. [More Information]
  • Horby, P., Gilmour, R., Wang, H., McIntyre, P. (2003). Progress towards eliminating Hib in Australia: An evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Communicable Diseases Intelligence Quarterly Report, 27(3), 324-341.
  • Leask, J., McIntyre, P. (2003). Public opponenets of vaccination: A case study. Vaccine, 11, 4700-4703. [More Information]
  • Lawrence, G., Menzies, R., Burgess, M., McIntyre, P., Wood, N., Boyd, I., Purcell, P., Isaacs, D. (2003). Survellance of adverse events following immunisation: Australia 2000-2002. Communicable Diseases Intelligence Quarterly Report, 27(3), 307-323.
  • MacIntyre, C., Gay, N., Gidding, H., Hull, B., Gilbert, G., McIntyre, P. (2002). A mathematical model to measure the impact of the Measles Control Campaign on the potential for measles transmission in Australia. International Journal of Infectious Diseases, 6, 277-282. [More Information]
  • Turnbull, F., McIntyre, P., Achat, H., Wang, H., Stapledon, R., Gold, M., Burgess, M. (2002). National study of adverse reactions after vaccination with Bacille Calmette-Guerin. Clinical Infectious Diseases, 34(4), 447-453. [More Information]
  • Jones, C., Isaacs, D., McIntyre, P., Cunningham, A., Garland, S. (2002). Neonatal herpes simplex virus infection. Ninth Annual Report, , 31-32.
  • Torvaldsen, S., McIntyre, P. (2002). Observational methods in epidemiologic assessment of vaccine effectiveness. Communicable Diseases Intelligence Quarterly Report, 26(3), 451-457.
  • Nolan, T., McIntyre, P., Roberton, D., Descamps, D. (2002). Reactogenicity and immunogenicity of a live attenuated tetravalent measles - mumps - rubella-varicella (MMRV) vaccine. Vaccine, 21(3-4), 281-289. [More Information]
  • McMaster, P., McIntyre, P., Gilmour, R., Gilbert, G., Kakakios, A., Mellis, C. (2002). The emergence of resistant pneumococcal meningitis - implications for empiric therapy. Archives of Disease in Childhood, 87(3), 207-211. [More Information]
  • Torvaldsen, S., Hull, B., McIntyre, P. (2002). Using the Australian Childhood Immunisation Register to track the transition from whole-cell to aceullular pertussis vaccines. Communicable Diseases Intelligence Quarterly Report, 26(4), 581-583.
  • Gilbert, G., Turnbull, F., McIntyre, P., Burgess, M., Escott,, R., Gidding, H., Heath, T. (2001). Impact of the Austalian measles control campaign on immunity to measles and rubella. Epidemiology and Infection, 127, 297-303.
  • MacIntyre, C., McIntyre, P. (2001). MMR, autism and inflammatory bowel disease: responding to patient concerns using an evidence-based framework. Medical Journal of Australia, 175, 127-128.
  • Turnbull, F., Burgess, M., McIntyre, P., Gilbert, G., Hull, B., Lambert, S., Gidding, H., Escott,, R., Achat, H., Wang, H., et al (2001). The Australian measles control campaign 1998. Bulletin of the World Health Organization, 79, 882-888.
  • Hull, B., McIntyre, P. (2000). A re-evaluation of immunisation coverage estimates from the Australian Childhood Immunisation Register. Communicable Diseases Intelligence Quarterly Report, 24(6), 161-164.
  • McIntyre, P., Nolan, T. (2000). Conjugate pneumococcal vaccines for non-indigenous children in Australia. Medical Journal of Australia, 173, S54-S57.
  • Guthridge, S., McIntyre, P., Isaacs, D., Hanlon, M., Patel, C. (2000). Differing serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian Aboriginal and Caucasian infants - implications for disease epidemiology. Vaccine, 18, 2584-2591.
  • McIntyre, P., Gilmour, R., Gilbert, G., Kakakios, A., Mellis, C. (2000). Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997-1999. Medical Journal of Australia, 173, 2-6.
  • Hull, B., McIntyre, P. (2000). Immunisation coverage reporting through the Australian Childhood Immunisation Register - an evaluation of the third-dose assumption. Australian and New Zealand Journal of Public Health, 24(1), 17-21. [More Information]
  • McIntyre, P., Gidding, H., Gilbert, G. (2000). Measles in an era of measles control. Medical Journal of Australia, 172, 103-104.
  • Hanlon, M., Nambiar, R., Kakakios, A., McIntyre, P., Land, M., Devine, P. (2000). Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole-call pertussis ELISA. Immunology and Cell Biology, 78, 254-258.
  • Thomas, P., McIntyre, P., Jalaludin, B. (2000). Survey of pertussis morbidity in adults in western Sydney. Medical Journal of Australia, 173, 74-76.
  • McIntyre, P., Amin, J., Gidding, H., Hull, B., Torvaldsen, S., Tucker, A., Turnbull, F., Burgess, M. (2000). Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998. Communicable Diseases Intelligence Quarterly Report, 24, 276-277.

Conferences

  • Menzies, R., Williams, K., McIntyre, P. (2005). Measuring vaccination coverage in Aboriginal and Torres Strait Islander children. The inaugural Indigenous Health Unit Research Day 2004, Sydney: UNSW Publishing.
  • Joseph, T., Menzies, R., McIntyre, P. (2005). Vaccination of Indigenous adults in the Community Controlled Sector - what is done and what works. The inaugural Indigenous Health Unit Research Day 2004, Sydney: UNSW Publishing.
  • Elliott, E., McIntyre, P., Ridley, G., Morris, A., Massie, J., McEniery, J., Knight, G. (2002). Hospitalised pertussis in infancy. RACP Annual Scientific Meeting, : British Medical Journal Publishing Group.

Magazine / Newspaper Articles

  • Lister, S., McIntyre, P., Menzies, R. (2000). The epidemiology of respiratory syncytial virus infections in NSW children, 1992-1997. NSW Public Health Bulletin.

Research Reports

  • Dey, A., Tashani, M., Clark, K., Hendry, A., Beard, F., McIntyre, P. (2018). Evaluation of the influenza immunisation program for Aboriginal and Torres Strait Islander children aged 6 months to <5 years, (pp. 1 - 48). Sydney, Australia: National Centre for Immunisation Research and Surveillance.

2019

  • Hull, B., Hendry, A., Dey, A., Beard, F., McIntyre, P., Brotherton, J. (2019). Immunisation coverage annual report, 2015. Communicable diseases intelligence (2018), 43(43), 1-45.

2018

  • Gunasekera, H., Miller, H., Burgess, L., Chando, S., Sheriff, S., Tsembis, J., Kong, K., Coates, H., Curotta, J., Falster, K., McIntyre, P., Craig, J., et al (2018). Agreement between diagnoses of otitis media by audiologists and otolaryngologists in Aboriginal Australian children. Medical Journal of Australia, 209(1), 29-35. [More Information]
  • Moore, H., Fathima, P., Gidding, H., de Klerk, N., Liu, B., Sheppeard, V., Effler, P., Snelling, T., McIntyre, P., Blyth, C. (2018). Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study. Vaccine, 36(28), 4062-4069. [More Information]
  • Karki, S., Muscatello, D., Banks, E., MacIntyre, C., McIntyre, P., Liu, B. (2018). Association between body mass index and laboratory-confirmed influenza in middle aged and older adults: a prospective cohort study. International Journal of Obesity, 42(8), 1480-1488. [More Information]
  • Edirisuriya, C., Beard, F., Hendry, A., Dey, A., Gidding, H., Hueston, L., Dwyer, D., Wood, J., Macartney, K., McIntyre, P. (2018). Australian rubella serosurvey 2012-2013: On track for elimination? Vaccine, 36(20), 2794-2798. [More Information]
  • Sheel, M., Beard, F., Quinn, H., Dey, A., Kirk, M., Koehler, A., Markey, P., McIntyre, P., Macartney, K. (2018). Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015. Communicable diseases intelligence (2018), 42, 1-27.
  • Gidding, H., Quinn, H., Hueston, L., Dwyer, D., McIntyre, P. (2018). Declining measles antibodies in the era of elimination: Australia's experience. Vaccine, 36(4), 507-513. [More Information]
  • Jayasinghe, S., Chiu, C., Quinn, H., Menzies, R., Gilmour, R., McIntyre, P. (2018). Effectiveness of 7- and 13-valent pneumococcal conjugate vaccines in a schedule without a booster dose: A 10-year observational study. Clinical Infectious Diseases, 67(3), 367-374. [More Information]
  • Gidding, H., McCallum, L., Fathima, P., Moore, H., Snelling, T., Blyth, C., Jayasinghe, S., Giele, C., de Klerk, N., Andrews, R., McIntyre, P. (2018). Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia. Vaccine, 36(19), 2650-2656. [More Information]
  • Dey, A., Tashani, M., Clark, K., Hendry, A., Beard, F., McIntyre, P. (2018). Evaluation of the influenza immunisation program for Aboriginal and Torres Strait Islander children aged 6 months to <5 years, (pp. 1 - 48). Sydney, Australia: National Centre for Immunisation Research and Surveillance.
  • McIntyre, P., Edwards, K. (2018). Genetically modified pertussis toxin: a quantum leap? The Lancet Infectious Diseases, 18(11), 1169-1171. [More Information]
  • Wood, N., Nolan, T., Marshall, H., Richmond, P., Gibbs, E., Perrett, K., McIntyre, P. (2018). Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial. JAMA Pediatrics, 172(11), 1045-1052. [More Information]
  • Whittaker, E., Goldblatt, D., McIntyre, P., Levy, O. (2018). Neonatal immunization: Rationale, current state, and future prospects. Frontiers in Immunology, 9, 1-10. [More Information]
  • Dyda, A., McIntyre, P., Karki, S., MacIntyre, C., Newall, A., Banks, E., Kaldor, J., Liu, B. (2018). Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program. Vaccine, 36(29), 4157-4160. [More Information]
  • Chen, C., Beutels, P., Wood, J., Menzies, R., MacIntyre, C., McIntyre, P., Newall, A. (2018). Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine, 36(42), 6307-6313. [More Information]
  • Cheah, B., Davies, J., Singh, G., Wood, N., Jackson, K., Littlejohn, M., Davison, B., McIntyre, P., Locarnini, S., Davis, J., et al (2018). Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia. Vaccine, 36(24), 3533-3540. [More Information]
  • Chen, C., Wood, J., Beutels, P., Menzies, R., MaCintyre, C., Dirmesropian, S., Reyes, J., McIntyre, P., Newall, A. (2018). The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia. Vaccine, 36(10), 1265-1271. [More Information]
  • Phillips, A., Beard, F., Macartney, K., Chan, J., Gilmour, R., Saravanos, G., McIntyre, P. (2018). Vaccine-preventable child deaths in New South Wales from 2005 to 2014: How much is preventable? Journal of Paediatrics and Child Health, 54(4), 356-364. [More Information]

2017

  • Reyes, J., Wood, J., Beutels, P., Macartney, K., McIntyre, P., Menzies, R., Mealing, N., Newall, A. (2017). Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine, 35(2), 345-352. [More Information]
  • Dirmesropian, S., Wood, J., MacIntyre, C., Beutels, P., McIntyre, P., Menzies, R., Reyes, J., Chen, C., Newall, A. (2017). Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians. Vaccine, 35(34), 4307-4314. [More Information]
  • Yin, K., Jayasinghe, S., Charles, P., King, C., Chiu, C., Menzies, R., McIntyre, P. (2017). Determining the contribution of Streptococcus pneumoniae to community-acquired pneumonia in Australia. Medical Journal of Australia, 207(9), 396-400. [More Information]
  • Archer, B., Chiu, C., Jayasinghe, S., Richmond, P., McVernon, J., Lahra, M., Andrews, R., McIntyre, P. (2017). Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: Priority populations for vaccination. Medical Journal of Australia, 207(9), 382-387. [More Information]
  • Macartney, K., Gidding, H., Trinh, L., Wang, H., Dey, A., Hull, B., Orr, K., McRae, J., Richmond, P., Gold, M., McIntyre, P., Wood, N., et al (2017). Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia. JAMA Pediatrics, 171(10), 992-998. [More Information]
  • Wiley, K., Regan, A., McIntyre, P. (2017). Immunisation and pregnancy - who, what, when and why? Australian Prescriber, 40(4), 122-124. [More Information]
  • Hull, B., Hendry, A., Dey, A., Beard, F., Brotherton, J., McIntyre, P. (2017). Immunisation coverage annual report, 2014. Communicable Diseases Intelligence, 41(1), E68-E90.
  • Trinh, L., Macartney, K., McIntyre, P., Chiu, C., Dey, A., Menzies, R. (2017). Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data. Vaccine, 35(11), 1524-1529. [More Information]
  • Jayasinghe, S., Menzies, R., Chiu, C., Toms, C., Blyth, C., Krause, V., McIntyre, P. (2017). Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014. Clinical Infectious Diseases, 64(2), 175-183. [More Information]
  • Beard, F., Leask, J., McIntyre, P. (2017). No jab, no pay and vaccine refusal in Australia: The jury is out. Medical Journal of Australia, 207(9), 407-407.e1. [More Information]
  • Beard, F., Leask, J., McIntyre, P. (2017). No jab, no pay and vaccine refusal in australia: The jury is out. Medical Journal of Australia, 206(9), 381-383. [More Information]
  • Pillsbury, A., Quinn, H., Evans, T., McIntyre, P., Brotherton, J. (2017). Population-level herd protection of males from a female human papillomavirus vaccination program: Evidence from australian serosurveillance. Clinical Infectious Diseases, 65(5), 827-832. [More Information]
  • Sheel, M., Beard, F., Dey, A., Macartney, K., McIntyre, P. (2017). Rates of hospitalisation for herpes zoster may warrant vaccinating indigenous Australians under 70. Medical Journal of Australia, 207(9), 395-396. [More Information]

2016

  • Sobanjo-ter Meulen, A., Duclos, P., McIntyre, P., Lewis, K., Van Damme, P., O'Brien, K., Klugman, K. (2016). Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries. Clinical Infectious Diseases, 63(suppl 4), S123-S133. [More Information]
  • Li-Kim-Moy, J., Yin, K., Patel, C., Beard, F., Chiu, C., Macartney, K., McIntyre, P. (2016). Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015. Communicable Diseases Intelligence Quarterly Report, 40(4), E482-E495.
  • Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., Marshall, H., McIntyre, P., Lan, R. (2016). Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. Vaccine, 34(34), 3967-3971. [More Information]
  • Hale, S., Quinn, H., Kesson, A., Wood, N., McIntyre, P. (2016). Changing Patterns of Pertussis in a Children's Hospital in the Polymerase Chain Reaction Diagnostic Era. The Journal of Pediatrics, 170, 161-165.e1. [More Information]
  • Karki, S., Dyda, A., Newall, A., Heywood, A., Macintyre, C., McIntyre, P., Banks, E., Liu, B. (2016). Comparison of influenza vaccination coverage between immigrant and Australian-born adults. Vaccine, 34(50), 6388-6395. [More Information]
  • Safarchi, A., Octavia, S., Wu, S., Kaur, S., Sintchenko, V., Gilbert, G., Wood, N., McIntyre, P., Marshall, H., Keil, A., et al (2016). Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. Journal of Infection, 72(4), 468-477. [More Information]
  • Chow, M., Khandaker, G., McIntyre, P. (2016). Global Childhood Deaths From Pertussis: A Historical Review. Clinical Infectious Diseases, 63(suppl 4), S134-S141. [More Information]
  • Karki, S., Newall, A., MacIntyre, C., Heywood, A., McIntyre, P., Banks, E., Liu, B. (2016). Healthcare resource utilisation associated with herpes zoster in a prospective cohort of older Australian adults. PloS One, 11(8), 1-13. [More Information]
  • Hull, B., Dey, A., Beard, F., Menzies, R., Brotherton, J., McIntyre, P. (2016). Immunisation coverage annual report, 2013. Communicable Diseases Intelligence, 40(1), e146-e169.
  • Campbell, P., McVernon, J., McIntyre, P., Geard, N. (2016). Influence of Population Demography and Immunization History on the Impact of an Antenatal Pertussis Program. Clinical Infectious Diseases, 63(suppl 4), S213-S220. [More Information]
  • McIntyre, P., Forrest, J. (2016). Margaret Anne Burgess. Medical Journal of Australia, 204(10), 389-391. [More Information]
  • Lawrence, G., Wang, H., Lahra, M., Booy, R., McIntyre, P. (2016). Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme. Epidemiology and Infection, 144(11), 2382-2391. [More Information]
  • Snelling, T., McIntyre, P. (2016). Modeling the Effects of Priming With the Whole-Cell Bordetella Pertussis Vaccine. JAMA Pediatrics, 170(12), 1228-1229. [More Information]
  • Newall, A., Reyes, J., McIntyre, P., Menzies, R., Beutels, P., Wood, J. (2016). Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical. Vaccine, 34(3), 320-327. [More Information]
  • Dey, A., Knox, S., Wang, H., Beard, F., McIntyre, P. (2016). Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2008-2011. Communicable Diseases Intelligence, 40(Suppl), S1-S70.
  • Pillsbury, A., Chiew, M., Bag, S., Hope, K., Norton, S., Conaty, S., Sheppeard, V., McIntyre, P. (2016). The changing epidemiology of measles in an era of elimination: lessons from health-care-setting transmissions of measles during an outbreak in New South Wales, Australia, 2012. Western Pacific Surveillance and Response, 7(3), 1-10. [More Information]
  • Clarke, M., McIntyre, P., Blyth, C., Wood, N., Octavia, S., Sintchenko, V., Giles, L., Quinn, H., Hill, V., Hanly, G., et al (2016). The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. Journal of Infection, 72(2), 171-178. [More Information]
  • Holt, P., Snelling, T., White, O., Sly, P., de Klerk, N., Carapetis, J., van den Biggelaar, A., Wood, N., McIntyre, P., Gold, M. (2016). Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine? Vaccine, 34(35), 4257-4262. [More Information]
  • Beard, F., Hull, B., Leask, J., Dey, A., McIntyre, P. (2016). Trends and patterns in vaccination objection, Australia, 2002-2013. Medical Journal of Australia, 204(7), 275.e1-275.e6. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2016). Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: Analysis of national hospital data. BMC Infectious Diseases, 16(1), 1-11. [More Information]

2015

  • Chiew, M., Dey, A., Martin, N., Wang, H., Davis, S., McIntyre, P. (2015). Australian vaccine preventable disease epidemiological review series: measles 2000-2011. Communicable Diseases Intelligence Quarterly Report, 39(1), e1-e9.
  • Gao, Z., Wood, J., Gidding, H., Newall, A., Menzies, R., Wang, H., McIntyre, P., MacIntyre, C. (2015). Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future. Epidemiology and Infection, 143(7), 1467-1476. [More Information]
  • Brouwer, M., McIntyre, P., Prasad, K., van der Beek, D. (2015). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 9, 1-108. [More Information]
  • Campbell, P., McCaw, J., McIntyre, P., McVernon, J. (2015). Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine, 33(43), 5794-5800. [More Information]
  • Wood, J., Goeyvaerts, N., MacIntyre, C., Menzies, R., McIntyre, P., Hens, N. (2015). Estimating vaccine coverage from serial trivariate serologic data in the presence of waning immunity. Epidemiology, 26(3), 381-389. [More Information]
  • Jayasinghe, S., Chiu, C., Menzies, R., Lehmann, D., Cook, H., Giele, C., Krause, V., McIntyre, P. (2015). Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children. Vaccine, 33(48), 6666-6674. [More Information]
  • Dyda, A., MacIntyre, C., McIntyre, P., Newall, A., Banks, E., Kaldor, J., Liu, B. (2015). Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program. Vaccine, 33(29), 3299-3305. [More Information]
  • Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2015). Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data. The Journal of Infectious Diseases, 211(1), 91-99. [More Information]
  • Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., Gold, M., Kynaston, J., Blyth, C., Zurynski, Y., Elliott, E., Booy, R., McIntyre, P., Wood, N., et al (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417. [More Information]
  • Brotherton, J., Condon, J., McIntyre, P., Tabrizi, S., Malloy, M., Garland, S. (2015). Human papillomavirus prevalence to age 60 years among Australian women prevaccination. Sexual Health, 12(4), 353-359. [More Information]
  • Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., et al (2015). International collaboration to assess the risk of Guillain BarrĂ© Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. [More Information]
  • Lowbridge, C., McIntyre, P., Gilmour, R., Chiu, C., Seale, H., Ferson, M., Gilbert, G. (2015). Long term population impact of seven-valent pneumococcal conjugate vaccine with a "3+0" schedule-How do "2+1" and "3+1" schedules compare? Vaccine, 33(28), 3234-3241. [More Information]
  • Menzies, R., Bremner, K., Wang, H., Beard, F., McIntyre, P. (2015). Long-Term Trends in Invasive Haemophilus influenzae Type b Disease among Indigenous Australian Children Following use of PRP-OMP and PRP-T Vaccines. Pediatric Infectious Disease Journal, 34(6), 621-626. [More Information]
  • Dyda, A., MacIntyre, C., Banks, E., Kaldor, J., Newall, A., McIntyre, P., Liu, B. (2015). Medicare Benefits Schedule data to monitor influenza immunisation in Australian adults. Public Health Research and Practice, 25(4), 1-6. [More Information]
  • Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., Marshall, H., McIntyre, P., Lan, R. (2015). Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine, 33(46), 6277-6281. [More Information]
  • Leach, A., Mulholland, E., Santosham, M., Torzillo, P., Brown, N., McIntyre, P., Smith-Vaughan, H., Skull, S., Balloch, A., Andrews, R., et al (2015). Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk indigenous infants (PREV-IX-COMBO): Protocol of a randomised controlled trial. BMJ Open, 5(1), 1-10. [More Information]
  • Menzies, R., Jardine, A., McIntyre, P. (2015). Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination. Clinical Infectious Diseases, 61(6), 927-933. [More Information]
  • Woods, J., Heywood, A., Menzies, R., McIntyre, P., MacIntyre, C. (2015). Predicting localised measles outbreak potential in Australia. Vaccine, 33(9), 1176-1181. [More Information]
  • Marshall, H., Clarke, M., Rasiah, K., Richmond, P., Buttery, J., Reynolds, G., Andrews, R., Nissen, M., Wood, N., McIntyre, P. (2015). Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatric Infectious Disease Journal, 34(4), 339-345. [More Information]
  • Karki, S., Gidding, H., Newall, A., McIntyre, P., Liu, B. (2015). Risk factors and burden of acute Q fever in older adults in New South Wales: a prospective cohort study. Medical Journal of Australia, 203(11), 438.e1-438.e6. [More Information]
  • Liu, B., Heywood, A., Reekie, J., Banks, E., Kaldor, J., McIntyre, P., Newall, A., MacIntyre, C. (2015). Risk factors for herpes zoster in a large cohort of unvaccinated older adults: A prospective cohort study. Epidemiology and Infection, 143(13), 2871-2881. [More Information]
  • Karki, S., McIntyre, P., Newall, A., MacIntyre, C., Banks, E., Liu, B. (2015). Risk factors for pertussis hospitalizations in Australians aged 45 years and over: A population based nested case-control study. Vaccine, 33(42), 5647-5653. [More Information]
  • Gibson, A., Jorm, L., McIntyre, P. (2015). Using linked birth, notification, hospital and mortality data to examine false-positive meningococcal disease reporting and adjust disease incidence estimates for children in New South Wales, Australia. Epidemiology and Infection, 143(12), 2570-2579. [More Information]

2014

  • MacIntyre, C., Ridda, I., Gao, Z., Moa, A., McIntyre, P., Sullivan, J., Jones, T., Hayen, A., Lindley, R. (2014). A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly. PloS One, 9(4), 1-14. [More Information]
  • Wood, N., Marshall, H., White, O., Holt, P., McIntyre, P. (2014). Antibody and cell-mediated immunity to pertussis 4 years after monovalent acellular pertussis vaccine at birth. Pediatric Infectious Disease Journal, 33(5), 511-517. [More Information]
  • Snelling, T., McIntyre, P. (2014). Assessing the effect of meningitis prevention and treatment. The Lancet Infectious Diseases, 14(9), 780-781. [More Information]
  • Pillsbury, A., Quinn, H., McIntyre, P. (2014). Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012. Communicable Diseases Intelligence Quarterly Report, 38(3), E179-194.
  • Khandaker, G., Zurynski, Y., Ridley, G., Buttery, J., Marshall, H., Richmond, P., Royle, J., Gold, M., Walls, T., Whitehead, B., McIntyre, P., Booy, R., Elliott, E., et al (2014). Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: A prospective national study. Influenza and Other Respiratory Viruses, 8(6), 636-645. [More Information]
  • Quinn, H., Snelling, T., Macartney, K., McIntyre, P. (2014). Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics, 133(3), e513-e519. [More Information]
  • Newall, A., Reyes, J., Wood, J., McIntyre, P., Menzies, R., Beutels, P. (2014). Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses. Vaccine, 32(7), 759-765. [More Information]
  • McCallum, L., Liu, B., McIntyre, P., Jorm, L. (2014). Estimating the burden of pertussis in young children on hospitals and emergency departments: a study using linked routinely collected data. Epidemiology and Infection, 142(4), 695-705. [More Information]
  • Chiew, M., Gidding, H., Dey, A., Wood, J., Martin, N., Davis, S., McIntyre, P. (2014). Estimating the measles effective reproduction number in Australia from routine notification data. Bulletin of the World Health Organization, 92(3), 171-177. [More Information]
  • Dey, A., Gidding, H., Menzies, R., McIntyre, P. (2014). General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events. Vaccine, 32(19), 2204-2208. [More Information]
  • Tabrizi, S., Brotherton, J., Stevens, M., Condon, J., McIntyre, P., Smith, D., Garland, S. (2014). HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. Journal Of Clinical Virology, 60(3), 250-256. [More Information]
  • Hull, B., Dey, A., Menzies, R., Brotherton, J., McIntyre, P. (2014). Immunisation coverage, 2012. Communicable Diseases Intelligence, 38(3), E208-E231.
  • Menzies, R., Krause, V., McIntyre, P. (2014). Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older: In Reply. Medical Journal of Australia, 201(4), 200.
  • Quinn, H., Wood, N., Cannings, K., Dey, A., Wang, H., Menzies, R., Moberley, S., Reid, S., McIntyre, P., Macartney, K. (2014). Intussusception after monovalent human rotavirus vaccine in Australia: Severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatric Infectious Disease Journal, 33(9), 959-965. [More Information]
  • Quinn, H., Snelling, T., Habig, A., Chiu, C., Spokes, P., McIntyre, P. (2014). Parental Tdap Boosters and Infant Pertussis: A Case-Control Study. Pediatrics, 134(4), 713-720. [More Information]
  • McIntyre, P., Nolan, T. (2014). Pertussis control: where to now? Improving protection against pertussis requires sorting the facts from the artefacts. Medical Journal of Australia, 200(6), 306-307. [More Information]
  • McIntyre, P., Clark, T. (2014). Pertussis vaccine in pregnancy-first dose for every infant. The Lancet, 384(9953), 1484-1486. [More Information]
  • Lam, C., Octavia, S., Ricafort, L., Sintchenko, V., Gilbert, G., Wood, N., McIntyre, P., Marshall, H., Guiso, N., Keil, A., et al (2014). Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerging Infectious Diseases, 20(4), 626-633. [More Information]
  • Macartney, K., Heywood, A., McIntyre, P. (2014). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 6, 1-45. [More Information]
  • Heywood, A., Wang, H., Macartney, K., McIntyre, P. (2014). Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bulletin of the World Health Organization, 92(8), 593-604. [More Information]

2013

  • Ward, K., Quinn, H., Menzies, R., McIntyre, P. (2013). A history of adolescent school-based vaccination in Australia. Communicable Diseases Intelligence Quarterly Report, 37(2), E168-E174. [More Information]
  • Ward, K., Quinn, H., Bachelor, M., Bryant, V., Campbell-Lloyd, S., Newbound, A., Skully, M., Webby, R., McIntyre, P. (2013). Adolescent school-based vaccination in Australia. Communicable Diseases Intelligence Quarterly Report, 37(2), E156-E167. [More Information]
  • Hull, B., Dey, A., Menzies, R., McIntyre, P. (2013). Annual immunisation coverage report, 2010. Communicable Diseases Intelligence Quarterly Report, 37(1), E21-E39. [More Information]
  • Gunaratnam, P., Gilmour, R., Lowbridge, C., McIntyre, P. (2013). Bug Breakfast in the Bulletin: invasive pneumococcal disease. NSW Public Health Bulletin, 24(3), 142-142. [More Information]
  • Marshall, H., McIntyre, P., Richmond, P., Buttery, J., Royle, J., Gold, M., Wood, N., Elliott, E., Zurynski, Y., Toi, C., Dwyer, D., Booy, R. (2013). Changes in Patterns of Hospitalized Children with Varicella and of Associated Varicella Genotypes After Introduction of Varicella Vaccine in Australia. Pediatric Infectious Disease Journal, 32(5), 530-537. [More Information]
  • Brouwer, M., McIntyre, P., Prasad, K., van de Beek, D. (2013). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 6, 1-100. [More Information]
  • Hull, B., Menzies, R., Macartney, K., McIntyre, P. (2013). Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: The Australian experience. Vaccine, 31(15), 1964-1969. [More Information]
  • Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., Macartney, K., et al (2013). International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. [More Information]
  • Carlin, J., Macartney, K., Lee, K., Quinn, H., Buttery, J., Lopert, R., Bines, J., McIntyre, P. (2013). Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clinical Infectious Diseases, 57(10), 1427-1434. [More Information]
  • Gao, Z., Wood, J., Burgess, M., Menzies, R., McIntyre, P., MacIntyre, C. (2013). Models of strategies for control of rubella and congenital rubella syndrome-A 40 year experience from Australia. Vaccine, 31(4), 691-697. [More Information]
  • Menzies, R., Markey, P., Boyd, R., Koehler, A., McIntyre, P. (2013). No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children. International Journal of Circumpolar Health, 72(Supplement 1), 1-6. [More Information]
  • Zurynski, Y., McIntyre, P., Booy, R., Elliott, E. (2013). Paediatric Active Enhanced Disease Surveillance: A new surveillance system for Australia. Journal of Paediatrics and Child Health, 49(7), 588-594. [More Information]
  • Chiu, C., McIntyre, P. (2013). Pneumococcal vaccines: past, present and future. Australian Prescriber, 36(3), 88-93a. [More Information]
  • Feikin, D., Kagucia, E., Loo, J., Link-Gelles, R., Puhan, M., Cherian, T., Levine, O., Jayasinghe, S., McIntyre, P., Menzies, R., et al (2013). Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites. PLoS Medicine, 10(9), 1-28. [More Information]
  • Wiley, K., Zuo, Y., Macartney, K., McIntyre, P. (2013). Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy. Vaccine, 31(4), 618-625. [More Information]
  • McIntyre, P., Sintchenko, V. (2013). The "How" of Polymerase Chain Reaction Testing for Bordetella pertussis Depends on the "Why". Clinical Infectious Diseases, 56(3), 332-334. [More Information]

2012

  • Song, N., Gao, Z., Wood, J., Hueston, L., Gilbert, G., MacIntyre, C., Quinn, H., Menzies, R., McIntyre, P. (2012). Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination. Vaccine, 30(27), 4073-4078. [More Information]
  • McIntyre, P., O'Brien, K., Greenwood, B., van de Beek, D. (2012). Effect of vaccines on bacterial meningitis worldwide. The Lancet, 380(9854), 1703-1711. [More Information]
  • Campbell, P., McIntyre, P., Quinn, H., Hueston, L., Gilbert, G., McVernon, J. (2012). Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in Australia. PloS One, 7(4), 1-7. [More Information]
  • Wood, N., Sheppeard, V., Cashman, P., Palasanthiran, P., Casacelli, M., Cannings, K., McIntyre, P. (2012). Influenza Vaccine Safety in Children Less Than 5 Years Old. The 2010 and 2011 Experience in Australia. Pediatric Infectious Disease Journal, 31(2), 199-202. [More Information]
  • Hull, B., Dey, A., Campbell-Lloyd, S., Menzies, R., McIntyre, P. (2012). NSW Annual Immunisation Coverage Report, 2011. NSW Public Health Bulletin, 23(9-10), 179-186. [More Information]
  • Liu, B., McIntyre, P., Kaldor, J., Quinn, H., Ridda, I., Banks, E. (2012). Pertussis in Older Adults: Prospective Study of Risk Factors and Morbidity. Clinical Infectious Diseases, 55(11), 1450-1456. [More Information]
  • Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2012). Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011. Communicable Diseases Intelligence Quarterly Report, 36(1), 114-119. [More Information]
  • Halperin, S., Bettinger, J., Greenwood, B., Harrison, L., Jelfs, J., Ladhani, S., McIntyre, P., Ramsay, M., Safadi, M. (2012). The changing and dynamic epidemiology of meningococcal disease. Vaccine, 30S(Suppl 2), B26-B36. [More Information]
  • Liu, B., Guthridge, S., Li, S., Markey, P., Krause, V., McIntyre, P., Sullivan, E., Ward, J., Wood, N., Kaldor, J. (2012). The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on. Vaccine, 30(50), 7309-7314. [More Information]
  • Ridda, I., Yin, K., King, C., MacIntyre, R., McIntyre, P. (2012). The importance of pertussis in older adults: A growing case for reviewing vaccination strategy in the elderly. Vaccine, 30(48), 6745-6752. [More Information]

2011

  • Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2011). Annual report: surveillance of adverse events following immunisation in Australia, 2010. Communicable Diseases Intelligence Quarterly Report, 35(4), 263-280. [More Information]
  • Gunasekera, H., Purcell, A., Eades, S., Banks, E., Wutzke, S., McIntyre, P., Redman, S., Woolfenden, S., Fernando, D., Craig, J. (2011). Healthy kids, health future: Ear health, speech and language among urban aboriginal children (the SEARCH study). Journal of Paediatrics and Child Health, 47(Suppl. 2), 6-6.
  • Garland, S., Brotherton, J., Condon, J., McIntyre, P., Stevens, M., David, S., Tabrizi, S. (2011). Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Medicine, 9(104), 1-13. [More Information]
  • Hull, B., Dey, A., Mahajan, D., Menzies, R., McIntyre, P. (2011). Immunisation coverage annual report, 2009. Communicable Diseases Intelligence Quarterly Report, 35(2), 132-148. [More Information]
  • Van Damme, P., McIntyre, P., Grimprel, E., Kuriyakose, S., Jacquet, J., Hardt, K., Messier, M., Van Der Meeren, O. (2011). Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix) in adults 55 years of age and over: a sub-analysis of four trials. Vaccine, 29, 5932-5939. [More Information]
  • Helms, C., Leask, J., Cooper, S., Chow, M., McIntyre, P. (2011). Implementation of mandatory immunisation of healthcare workers: Observations from New South Wales, Australia. Vaccine, 29(16), 2895-2901. [More Information]
  • Buttery, J., Danchin, M., Lee, K., Carlin, J., McIntyre, P., Elliott, E., Booy, R., Bines, J. (2011). Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia. Vaccine, 29(16), 3061-3066. [More Information]
  • Hull, B., Dey, A., Campbell-Lloyd, S., Menzies, R., McIntyre, P. (2011). NSW Annual Immunisation Coverage Report, 2010. NSW Public Health Bulletin, 22(9-10), 179-195. [More Information]
  • Quinn, P., Gold, M., Royle, J., Buttery, J., Richmond, P., McIntyre, P., Wood, N., Lee, S., Marshall, H. (2011). Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine, 29(25), 4230-4237. [More Information]
  • Foxwell, A., McIntyre, P., Quinn, H., Roper, K., Clements, M. (2011). Severe Pertussis in Infants: Estimated Impact of First Vaccine Dose at 6 Versus 8 Weeks in Australia. Pediatric Infectious Disease Journal, 30(2), 161-163. [More Information]
  • Mahajan, D., Menzies, R., Cook, J., Macartney, K., McIntyre, P. (2011). Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010. Communicable Diseases Intelligence Quarterly Report, 35(1), 21-28. [More Information]
  • Quinn, H., McIntyre, P. (2011). The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia. Bulletin of the World Health Organization, 89(9), 666-674. [More Information]
  • Quinn, H., Mahajan, D., Hueston, L., Campbell, P., Menzies, R., Gilbert, G., McIntyre, P. (2011). The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules. NSW Public Health Bulletin, 22(11-12), 224-229. [More Information]

2010

  • Wood, N., McIntyre, P. (2010). 1st International Neonatal and Maternal Immunization Symposium. Expert Review of Obstetrics and Gynecology, 5(5), 507-509.
  • Wood, N., McIntyre, P., Marshall, H., Roberton, D. (2010). Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age. Pediatric Infectious Disease Journal, 29(3), 209-215. [More Information]
  • McIntyre, P. (2010). Adjunctive dexamethasone in meningitis: does value depend on clinical setting? The Lancet Neurology, 9(3), 229-231. [More Information]
  • Jardine, A., Deeks, S., Patel, M., Menzies, R., Gilbert, G., McIntyre, P. (2010). An evaluation of the Australian National Serosurveillance Program. Communicable Diseases Intelligence Quarterly Report, 34(1), 29-36. [More Information]
  • Mahajan, D., Roomiani, I., Gold, M., Lawrence, G., McIntyre, P., Menzies, R. (2010). Annual report: surveillance of adverse events following immunisation in Australia, 2009. Communicable Diseases Intelligence Quarterly Report, 34(3), 259-276. [More Information]
  • Burgess, M., McIntyre, P., Hellard, M., Ruff, T., Lefevre, I., Bock, H. (2010). Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Vaccine, 28(10), 2222-2226. [More Information]
  • Brouwer, M., McIntyre, P., de Gans, J., Prasad, K., van de Beek, D. (2010). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 1(9), 1-122. [More Information]
  • Wood, N., McIntyre, P. (2010). Epiglottitis: Going, going, but not gone yet. Journal of Paediatrics and Child Health, 46, 446. [More Information]
  • Ladhani, S., Heath, P., Slack, M., McIntyre, P., Diez-Domingo, J., Campos, J., Dagan, R., Ramsay, M., European Union Invasive Bacterial Infections Surveillance (EU-IBIS) Network, -. (2010). Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clinical Microbiology and Infection, 16(7), 948-954. [More Information]
  • Brotherton, J., Kaldor, J., McIntyre, P. (2010). HPV related surveillance activities in Australia. Vaccine, 28(47), 7453-7454. [More Information]
  • Gold, M., Buttery, J., McIntyre, P. (2010). Human Papillomavirus Vaccine Safety in Australia: Experience to Date and Issues for Surveillance. Sexual Health, 7(3), 320-324. [More Information]
  • McIntyre, P., Macartney, K., Gilroy, N., Lester, R. (2010). Immunisation. In A Yung, D Spelman, A Street, J McCormack, T Sorrell, P Johnson (Eds.), Infectious Diseases: A clinical approach, (pp. 648-666). Melbourne: IP Communications.
  • Hull, B., Mahajan, D., Dey, A., Menzies, R., McIntyre, P. (2010). Immunisation coverage annual report, 2008. Communicable Diseases Intelligence Quarterly Report, 34(3), 241-258. [More Information]
  • Ridda, I., MacIntyre, C., Lindley, R., McIntyre, P., Brown, M., Oftadeh, S., Sullivan, J., Gilbert, G. (2010). Lack of pneumococcal carriage in the hospitalised elderly. Vaccine, 28(23), 3902-3904. [More Information]
  • Leask, J., Helms, C., Chow, M., Cooper, S., McIntyre, P. (2010). Making influenza vaccination mandatory for health care workers: the views of NSW Health administrators and clinical leaders. NSW Public Health Bulletin, 21(9-10), 243-247. [More Information]
  • Leask, J., Booy, R., McIntyre, P. (2010). MMR, Wakefield and The Lancet: what can we learn? Medical Journal of Australia, 193(1), 5-7. [More Information]
  • Hull, B., Dey, A., Mahajan, D., Campbell-Lloyd, S., Menzies, R., McIntyre, P. (2010). NSW Annual Immunisation Coverage Report, 2009. NSW Public Health Bulletin, 21, 210-223. [More Information]
  • Marshall, H., McIntyre, P., Roberton, D., Dinan, L., Hardt, K. (2010). Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. International Journal of Infectious Diseases, 14(1), E41-E49. [More Information]
  • Isaacs, D., Macartney, K., McIntyre, P. (2010). Rapid Response: Benefits and risks of childhood influenza vaccination. BMJ, , 1.
  • Jardine, A., Menzies, R., McIntyre, P. (2010). Reduction in Hospitalizations for Pneumonia Associated with the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia. Pediatric Infectious Disease Journal, 29(7), 607-612. [More Information]
  • Gunasekera, H., Knox, S., Morris, P., Britt, H., McIntyre, P., Craig, J. (2010). Spectrum and management of otitis media in Australian indigenous and non-indigenous children: a national study. Pediatrics, 121(S2), S128-S128.
  • White, O., Rowe, J., Richmond, P., Marshall, H., McIntyre, P., Wood, N., Holt, P. (2010). Th2-polarisation of Cellular Immune Memory to Neonatal Pertussis Vaccination. Vaccine, 28(14), 2648-2652. [More Information]
  • McIntyre, P., Durrheim, D., Campbell-Lloyd, S. (2010). The NSW Immunisation Strategy 2008-2011: how are we doing? NSW Public Health Bulletin, 21, 193-195. [More Information]
  • Quinn, H., McIntyre, P., Backhouse, J., Gidding, H., Brotherton, J., Gilbert, L. (2010). The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiology and Infection, 138(3), 426-433. [More Information]
  • Chiu, C., Dey, A., Wang, H., Menzies, R., Deeks, S., Mahajan, D., Macartney, K., Jardine, A., Quinn, H., Jelfs, J., Booy, R., Lawrence, G., Wood, N., McIntyre, P., et al (2010). Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence Quarterly Report, 34, S1-167. [More Information]

2009

  • Menzies, R., Mahajan, D., Gold, M., Roomiani, I., McIntyre, P., Lawrence, G. (2009). Annual report: surveillance of adverse events following immunisation in Australia, 2008. Communicable Diseases Intelligence Quarterly Report, 33(4), 365-381. [More Information]
  • Gidding, H., Wallace, C., Lawrence, G., McIntyre, P. (2009). Australia's national Q fever vaccination program. Vaccine, 27(14), 2037-2041. [More Information]
  • McIntyre, P., Burgess, M., Egan, A., Schuerman, L., Hoet, B. (2009). Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination. Vaccine, 27(7), 1062-1066. [More Information]
  • Heywood, A., Gidding, H., Riddell, M., McIntyre, P., Macintyre, C., Kelly, H. (2009). Elimination of endemic measles transmission in Australia. Bulletin of the World Health Organization, 87(1), 64-71. [More Information]
  • Hull, B., Deeks, S., Menzies, R., McIntyre, P. (2009). Immunisation coverage annual report, 2007. Communicable Diseases Intelligence Quarterly Report, 33(2), 170-187. [More Information]
  • Ridda, I., MacIntyre, C., Lindley, R., Gao, Z., Sullivan, J., Yuan, F., McIntyre, P. (2009). Immunological responses to pneumococcal vaccine in frail older people. Vaccine, 27(10), 1628-1636. [More Information]
  • Gunasekera, H., Morris, P., McIntyre, P., Craig, J. (2009). Management of children with otitis media: a summary of evidence from recent systematic reviews. Journal of Paediatrics and Child Health, 45(10), 554-562. [More Information]
  • Simpkins, D., Wood, N., McIntyre, P., Menzies, R., Booy, R. (2009). Modern trends in mortality from meningococcal disease in Australia. Pediatric Infectious Disease Journal, 28(12), 1119-1120. [More Information]
  • McIntyre, P., Brotherton, J., Burgess, M. (2009). More data from Australia on sensitivity to HPV vaccine. BMJ, 338, b26. [More Information]
  • McIntyre, P., Wood, N. (2009). Pertussis in early infancy: disease burden and preventive strategies. Current Opinion in Infectious Diseases, 22(3), 215-223. [More Information]
  • Rank, C., Quinn, H., McIntyre, P. (2009). Pertussis Vaccine Effectiveness After Mass Immunization of High School Students in Australia. Pediatric Infectious Disease Journal, 28(2), 152-153. [More Information]
  • Wood, J., Gidding, H., Heywood, A., Macartney, K., McIntyre, P., MacIntyre, C. (2009). Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine, 27(2), 313-318. [More Information]
  • Hull, B., Deeks, S., McIntyre, P. (2009). The Australian Childhood Immunisation Register-A model for universal immunisation registers? Vaccine, 27(37), 5054-5060. [More Information]
  • Jardine, A., Menzies, R., Deeks, S., Patel, M., McIntyre, P. (2009). The Impact of Pneumococcal Conjugate Vaccine on Rates of Myringotomy With Ventilation Tube Insertion in Australia. Pediatric Infectious Disease Journal, 28(9), 761-765. [More Information]
  • Leask, J., McIntyre, P. (2009). Vaccine refusal and the risks of vaccine-preventable diseases. New England Journal of Medicine, 361(7), 723. [More Information]

2008

  • Brotherton, J., Kemp, A., McIntyre, P., Burgess, M., Gold, M., Campbell-Lloyd, S. (2008). Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ, 179(6), 525-533. [More Information]
  • Lawrence, G., Gold, M., Hill, R., Deeks, S., Glasswell, A., McIntyre, P. (2008). Annual report: surveillance of adverse events following immunisation in Australia, 2007. Communicable Diseases Intelligence Quarterly Report, 32(4), 371-87. [More Information]
  • Begg, K., Roche, P., Owen, R., Liu, C., Kaczmarek, M., McIntyre, P., Menzies, R., East, I., Coleman, D., O'Neill, K., et al (2008). Australia's notifiable diseases status, 2006, Annual Report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence Quarterly Report, 32, 139-207.
  • Yuan, F., Marks, K., Wong, M., Watson, S., de Leon, E., McIntyre, P., Sullivan, J. (2008). Clinical relevance of TLR2, TLR4, CD14 and FccRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunology and Cell Biology, 86, 268-270. [More Information]
  • Ridda, I., Lindley, R., McIntyre, P., MacIntyre, C., Gao, Z. (2008). Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine, 26(44), 5633-5640. [More Information]
  • Wood, N., Warlow, M., Quinn, H., Selvey, C., Lum, G., McIntyre, P., Kaldor, J. (2008). Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia. Australian and New Zealand Journal of Public Health, 32(3), 272-275. [More Information]
  • Ridda, I., Motbey, C., Lam, L., Lindley, R., McIntyre, P., MacIntyre, C. (2008). Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge. Vaccine, 26(2), 234-240. [More Information]
  • McIntyre, P., Leask, J. (2008). Improving uptake of MMR vaccine. British Medical Journal, 336(7647), 729-730. [More Information]
  • Wood, N., Quinn, H., McIntyre, P., Elliott, E. (2008). Pertussis in infants: preventing deaths and hospitalisations in the very young. Journal of Paediatrics and Child Health, 44(4), 161-165. [More Information]
  • Wood, N., McIntyre, P. (2008). Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatric Respiratory Reviews, 9(3), 201-11; quiz 211-2. [More Information]
  • Newall, A., Brotherton, J., Quinn, H., McIntyre, P., Backhouse, J., Gilbert, L., Esser, M., Erick, J., Bryan, J., Formica, N., MacIntyre, C. (2008). Population Seroprevalence of Human Papillo-mavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia. Clinical Infectious Diseases, 46(11), 1647-1655. [More Information]
  • Aratchige, P., McIntyre, P., Quinn, H., Gilbert, G. (2008). Recent increases in mumps incidence in Australia: the "forgotten" age group in the 1998 Australian Measles Control Campaign. Medical Journal of Australia, 189(8), 434-437. [More Information]
  • Ward, K., McIntyre, P., Kirkwood, C., Roche, P., Ferson, M., Van Buynder, P., Roberts-Witteveen, A., Kesson, A., Krause, V. (2008). Rotavirus surveillance in Australia. Communicable Diseases Intelligence Quarterly Report, 32(1), 82-87. [More Information]
  • Cagney, M., McIntyre, P., Heron, L., Giammanco, A., MacIntyre, C. (2008). The relationship between pertussis symptomatology, incidence and serology in adolescents. Vaccine, 26(44), 5547-5553. [More Information]
  • Wang, H., Deeks, S., Glasswell, A., McIntyre, P. (2008). Trends in invasive haemophilus influenzae type B disease in Australia, 1995-2005. Communicable Diseases Intelligence Quarterly Report, 32(3), 316-25. [More Information]
  • Ridley, G., Menzies, R., McIntyre, P. (2008). Update on childhood pneumococcal vaccination. Pediatric Health, 2(3), 351-365.
  • Menzies, R., Turnour, C., Chiu, C., McIntyre, P. (2008). Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 2003 to 2006. Communicable Diseases Intelligence Quarterly Report, 32(Supplement), S2-S67. [More Information]
  • Macartney, K., McIntyre, P. (2008). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 2008 (3), CD001833-1-CD001833-27. [More Information]
  • Hull, B., Deeks, S., Menzies, R., McIntyre, P. (2008). What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children? A 2007 update. Communicable Diseases Intelligence Quarterly Report, 32(2), 257-60. [More Information]

2007

  • Lawrence, G., Aratchige, P., Boyd, I., McIntyre, P., Gold, M. (2007). Annual report on surveillance of adverse events following immunisation in Australia, 2006. Communicable Diseases Intelligence Quarterly Report, 31(3), 269-282. [More Information]
  • Owen, R., Roche, P., Hope, K., Yohannes, K., Roberts, A., Liu, C., Stirzaker, S., Kong, F., Bartlett, M., Donovan, B., McIntyre, P., et al (2007). Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence Quarterly Report, 31(1), 1-70. [More Information]
  • Hull, B., McIntyre, P. (2007). Compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia. Communicable Diseases Intelligence Quarterly Report, 31, 198-202. [More Information]
  • van de Beek, D., de Gans, J., McIntyre, P., Prasad, K. (2007). Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews, 1(Art. No.: CD004405), DOI: 10.1002/14651858.CD004405.pub2. [More Information]
  • Macartney, K., MacIntyre, C., McIntyre, P. (2007). Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006. Communicable Diseases Intelligence Quarterly Report, 31(3), 303-310. [More Information]
  • MacIntyre, C., Burgess, M., Isaacs, D., McIntyre, P., Menzies, R., Hull, B. (2007). Epidemiology of severe hepatitis A in Indigenous Australian children. Journal of Paediatrics and Child Health, 43(5), 383-387. [More Information]
  • Quinn, H., McIntyre, P. (2007). Pertussis epidemiology in Australia over the decade 1995-2005: trends by region and age group. Communicable Diseases Intelligence Quarterly Report, 31(2), 205-215. [More Information]
  • Elliott, E., McIntyre, P., Wood, N. (2007). Pertussis in infancy: a review of strategies for prevention. SII Csalud, , 0-0.
  • Ridda, I., MacIntyre, C., Lindley, R., McIntyre, P., Sullivan, J., Gilbert, G., Kovoor, P., Manolios, N., Fox, J. (2007). Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Human Vaccines, 3(3), 57-60. [More Information]
  • Gidding, H., Wood, J., MacIntyre, C., Kelly, H., Lambert, S., Gilbert, G., McIntyre, P. (2007). Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine, 25(18), 3574-3580. [More Information]
  • Gidding, H., Warlow, M., MacIntyre, C., Backhouse, J., Gilbert, L., Quinn, H., McIntyre, P. (2007). The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine, 25(51), 8637-8641. [More Information]
  • Gunasekera, H., Knox, S., Morris, P., Britt, H., McIntyre, P., Craig, J. (2007). The spectrum and management of otitis media in Australian Indigenous and non-Indigenous children: a national study. Pediatric Infectious Disease Journal, 26(8), 689-692. [More Information]
  • Brotherton, J., Wang, H., Schaffer, A., Quinn, H., Menzies, R., Hull, B., Lawrence, C., Wood, J., Wood, N., Rosewell, A., Newall, A., Macartney, K., Gidding, H., McIntyre, P., Booy, R., et al (2007). Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report, 31(Suppl June 2007), 1-152. [More Information]
  • Menzies, R., McIntyre, P., Reid, R., O'Brien, K., Santosham, M., Watt, J., Moberley, S., Stirling, J., Gooda, M., Green, M., et al (2007). Vaccine preventable diseases in indigenous populations-International perspectives Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia. Vaccine, 25, 7281-4. [More Information]

2006

  • Lawrence, G., Boyd, I., McIntyre, P., Isaacs, D. (2006). Annual report: Surveillance of adverse events following immunisation in Australia, 2005. Communicable Diseases Intelligence Quarterly Report, 30(3), 319-333. [More Information]
  • Gubbay, J., McIntyre, P., Gilmour, R. (2006). Cellulitis in childhood invasive pneumococcal disease: a population-based study. Journal of Paediatrics and Child Health, 42(6), 354-358. [More Information]
  • Backhouse, J., Gidding, H., McIntyre, P., Gilbert, G. (2006). Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clinical and Vaccine Immunology, 13(7), 764-767. [More Information]
  • Kolos, V., Menzies, R., McIntyre, P. (2006). Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination. Vaccine, 25, 588-590. [More Information]
  • Beard, F., McIntyre, P., Gidding, H., Watson, M. (2006). Influenza related hospitalisations in Sydney, New South Wales, Australia. Archives of Disease in Childhood, 91(1), 20-25. [More Information]
  • Backhouse, J., Gidding, H., MacIntyre, C., McIntyre, P., Gilbert, G. (2006). Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia. Vaccine, 25(7), 1310-1315. [More Information]
  • McIntyre, P., Quinn, H. (2006). Tetanus in the elderly-An important preventable disease in Australia. Vaccine, 25(7), 1304-1309. [More Information]
  • Watson, M., Gilmour, R., Menzies, R., Ferson, M., McIntyre, P., New South Wales, P. (2006). The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clinical Infectious Diseases, 42(2), 211-215. [More Information]
  • Cagney, M., MacIntyre, C., McIntyre, P., Giammanco, A., PUECH, M. (2006). The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiology and Infection, 134(6), 1208-1216. [More Information]
  • Hull, B., McIntyre, P. (2006). Timeliness of childhood immunisation in Australia. Vaccine, 24(20), 4403-4408. [More Information]
  • Wood, N., McIntyre, P., Wong, M. (2006). Vaccination for the paediatrician. Journal of Paediatrics and Child Health, 42, 665-673. [More Information]
  • Menzies, R., McIntyre, P. (2006). Vaccine Preventable Diseases and Vaccination Policy for Indigenous Populations. Epidemiologic Reviews, 28, 71-80. [More Information]
  • Clements, C., McIntyre, P. (2006). When science is not enough - a risk/benefit profile of thiomersal-containing vaccines. Expert Opinion on Drug Safety, 5(1), 17-29. [More Information]

2005

  • Horby, P., MacIntyre, C., McIntyre, P., Gilbert, G., Staff, M., Hanlon, M., Heron, L., Cagney, M., Bennett, C. (2005). A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiology and Infection, 133(2), 229-236. [More Information]
  • McIntyre, P., MacIntyre, C., Gilmour, R., Wang, H. (2005). A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Archives of Disease in Childhood, 90(4), 391-396. [More Information]
  • Lawrence, G., Boyd, I., McIntyre, P., Isaacs, D. (2005). Annual report: surveillance of adverse events following immunisation in Australia, 2004. Communicable Diseases Intelligence Quarterly Report, 29(3), 248-62. [More Information]
  • Cagney, M., MacIntyre, C., McIntyre, P., Peat, J. (2005). Childhood asthma diagnosis and use of asthma medication. Australian Family Physician, 34(3), 193-196. [More Information]
  • Cagney, M., MacIntyre, C., McIntyre, P., Torvaldsen, S., Melot, V. (2005). Cough symptoms in children aged 5-14 years in Sydney, Australia: non-specific cough or unrecognized pertussis? Respirology, 10(3), 359-364. [More Information]
  • Wood, N., Menzies, R., McIntyre, P. (2005). Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease. Internal Medicine Journal, 35(9), 530-535. [More Information]
  • Wood, N., Backhouse, J., Gidding, H., Gilbert, G., Lum, G., McIntyre, P. (2005). Estimates of chronic hepatitis B virus infection in the Northern Territory. Communicable Diseases Intelligence Quarterly Report, 29(3), 289-290. [More Information]
  • McIntyre, P., Lester, R. (2005). Immunisation. In A Yung, D Spelman, A Street, J McCormack, T Sorrell, P Johnson (Eds.), Infectious Diseases: A clinical approach, (pp. 560-577). Melbourne: IP Communications.
  • McIntyre, P., Kelly, H., Mulholland, E. (2005). Immunisation at the crossroads: 9th National Immunisation/1st Asia-Pacific Vaccine Preventable Diseases Conference. Medical Journal of Australia, 182(1), 15-16. [More Information]
  • McIntyre, P. (2005). Immunisation: reducing health inequality for Indigenous Australians. Medical Journal of Australia, 182(5), 207-8. [More Information]
  • Andrews, R., Skull, S., Byrnes, G., Campbell, D., Turner, J., McIntyre, P., Kelly, H. (2005). Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria. Communicable Diseases Intelligence Quarterly Report, 29(3), 283-288. [More Information]
  • Isaacs, D., McIntyre, P. (2005). Influenza vaccines in healthy children. The Lancet, 365(9477), 2086-2086. [More Information]
  • Menzies, R., Williams, K., McIntyre, P. (2005). Measuring vaccination coverage in Aboriginal and Torres Strait Islander children. The inaugural Indigenous Health Unit Research Day 2004, Sydney: UNSW Publishing.
  • McIntyre, P. (2005). Should dexamethasone be part of routine therapy of bacterial meningitis in industrialised countries? Advances in Experimental Medicine and Biology, 568, 189-197. [More Information]
  • Macartney, K., McIntyre, P. (2005). Universal varicella vaccination. Comment. Medical Journal of Australia, 183(5), 278-9. [More Information]
  • Joseph, T., Menzies, R., McIntyre, P. (2005). Vaccination of Indigenous adults in the Community Controlled Sector - what is done and what works. The inaugural Indigenous Health Unit Research Day 2004, Sydney: UNSW Publishing.
  • Gilbert, G., Gidding, H., Backhouse, J., McIntyre, P. (2005). Varicella seroprevalence and vaccine uptake in preschool children. Medical Journal of Australia, 182(1), 42-42.
  • Gilbert, G., Gidding, H., Backhouse, J., McIntyre, P. (2005). Varicella seroprevalence and vaccine uptake in preschool children. Medical Journal of Australia, 182(1), 42. [More Information]
  • Macartney, K., Beutels, P., McIntyre, P., Burgess, M. (2005). Varicella vaccination in Australia. Journal of Paediatrics and Child Health, 41(11), 544-552. [More Information]

2004

  • Leask, J., Williams, A., McIntyre, P., O'Dea, D. (2004). Are General Practice Registrars Prepared For Immunisation? A Cross Sectional Survey. Australian Family Physician, 33(8), 665-667.
  • Andrews, R., Counahan, M., Hogg, G., McIntyre, P. (2004). Effectiveness Of A Publicly Funded Pneumococcal Vaccination Program Against Invasive Pneumococcal Disease Among The Elderly In Victoria, Australia. Vaccine, 23(2), 132-138. [More Information]
  • Lawrence, G., MacIntyre, C., McIntyre, P., Hull, B. (2004). Effectiveness Of The Linkage Of Child Care And Maternity Payments To Childhood Immunisation. Vaccine, 22(17-18), 2345-2350. [More Information]
  • Hull, B., McIntyre, P., Couzos, S. (2004). Evaluation Of Immunisation Coverage For Aboriginal And Torres Strait Islander Children Using The Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health, 28(1), 47-52. [More Information]
  • McIntyre, P., Turnbull, F., Egan, A., Burgess, M., Wolter, J., Schuerman, L. (2004). High Levels Of Antibody In Adults Three Years After Vaccination With A Reduced Antigen Content Diphtheria-Tetanus-Acellular Pertussis Vaccine. Vaccine, 23(2), 380-5. [More Information]
  • Elliott, E., McIntyre, P., Ridley, G., Morris, A., Massie, J., McEniery, J., Knight, G. (2004). National Study Of Infants Hospitalized With Pertussis In The Acellular Vaccine Era. Pediatric Infectious Disease Journal, 23(3), 246-252. [More Information]
  • Scuffham, P., McIntyre, P. (2004). Pertussis Vaccination Strategies For Neonates--An Exploratory Cost-Effectiveness Analysis. Vaccine, 22(21-22), 2953-2964. [More Information]
  • Belshe, R., Newman, F., Tsai, T., Karron, R., Reisinger, K., Roberton, D., Marshall, H., Schwartz, R., King, J., et al, McIntyre, P. (2004). Phase 2 Evaluation Of Parainfluenza Type 3 Cold Passage Mutant 45 Live Attenuated Vaccine In Healthy Children 6-18 Months Old. The Journal of Infectious Diseases, 189(3), 462-470. [More Information]
  • Brotherton, J., McIntyre, P. (2004). Planning for human papillomavirus vaccines in Australia: Report of a research group meeting. Communicable Diseases Intelligence Quarterly Report, 28(2), 249-254.
  • Lawrence, G., Hull, B., MacIntyre, C., McIntyre, P. (2004). Reasons For Incomplete Immunisation Among Australian Children. A National Survey Of Parents. Australian Family Physician, 33(7), 568-571.
  • van de Beek, D., de Gans, J., McIntyre, P., Prasad, K. (2004). Steroids In Adults With Acute Bacterial Meningitis: A Systematic Review. The Lancet Infectious Diseases, 4(3), 139-143. [More Information]
  • Lawrence, G., Boyd, I., McIntyre, P., Isaacs, D. (2004). Surveillance Of Adverse Events Following Immunisation: Australia 2002 To 2003. Communicable Diseases Intelligence Quarterly Report, 28(3), 324-338.
  • Poynten, M., McIntyre, P., Mooi, F., Heuvelman, K., Gilbert, G. (2004). Temporal Trends In Circulating Bordetella Pertussis Strains In Australia. Epidemiology and Infection, 132(2), 185-193. [More Information]
  • Butler, J., McIntyre, P., MacIntyre, C., Gilmour, R., Howarth, A., Sander, B. (2004). The Cost-Effectiveness Of Pneumococcal Conjugate Vaccination In Australia. Vaccine, 22(9-10), 1138-1149. [More Information]
  • Hethcote, H., Horby, P., McIntyre, P. (2004). Using Computer Simulations To Compare Pertussis Vaccination Strategies In Australia. Vaccine, 22(17-18), 2181-2191. [More Information]
  • Menzies, R., McIntyre, P., Beard, F. (2004). Vaccine Preventable Diseases And Vaccination Coverage In Aboriginal And Torres Strait Islander People, Australia, 1999 To 2002. Communicable Diseases Intelligence Quarterly Report, 28(2), 127-159.
  • Brotherton, J., McIntyre, P., PUECH, M., Wang, H., Gidding, H., Hull, B., Lawrence, G., MacIntyre, C., Wood, N., Armstrong, D. (2004). Vaccine Preventable Diseases And Vaccination Coverage In Australia 2001 To 2002. Communicable Diseases Intelligence Quarterly Report, 28(Supplement 2), vii-S116.
  • McIntyre, P. (2004). Vaccines for other neonatal infections: vaccination strategies for the prevention of neonatal pertussis. Expert Review of Vaccines, 3(4), 375-378. [More Information]
  • Hull, B., McIntyre, P. (2004). What Do We Know About 7Vpcv Coverage In Aboriginal And Torres Strait Islander Children? Communicable Diseases Intelligence Quarterly Report, 28(2), 238-243.

2003

  • MacIntyre, C., McIntyre, P., Cagney, M. (2003). Community-based estimates of incidence and risk factors for childhood pneumonia in Western Sydney. Epidemiology and Infection, 131(3), 1091-1096. [More Information]
  • van de Beek, D., de Gans, J., McIntyre, P., Prasad, K. (2003). Corticosteroids in acute bacterial meningitis. Cochrane Database of Systematic Reviews, 24(1), 1-27. [More Information]
  • Bonacruz-Kazzi, G., McIntyre, P., Hanlon, M., Menzies, R. (2003). Diagnostic testing and discharge coding for whooping cough in a children's hospital. Journal of Paediatrics and Child Health, 39(8), 586-590. [More Information]
  • Torvaldsen, S., McIntyre, P. (2003). Do variations in pertussis notifications reflect incidence or surveillance practices? A comparison of infant notification rates and hospitalisation data in NSW. NSW Public Health Bulletin, 14(4-5), 81-84.
  • Torvaldsen, S., McIntyre, P. (2003). Effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatric Infectious Disease Journal, 22(11), 956-959. [More Information]
  • Torvaldsen, S., Simpson, J., McIntyre, P. (2003). Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998. European Journal Of Epidemiology, 18(1), 63-69. [More Information]
  • Hull, B., Lawrence, G., MacIntyre, C., McIntyre, P. (2003). Estimating immunisation coverage: is the 'third dose assumption' still valid? Communicable Diseases Intelligence Quarterly Report, 27(3), 357-361.
  • MacIntyre, C., Burgess, M., Hull, B., McIntyre, P. (2003). Hepatitis A vaccination options for Australia. Journal of Paediatrics and Child Health, 39(2), 83-87. [More Information]
  • Hull, B., Lawrence, G., MacIntyre, C., McIntyre, P. (2003). Immunisation coverage in Australia corrected for under-reporting to the Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health, 27(5), 533-538. [More Information]
  • Hull, B., Lawrence, G., MacIntyre, C., McIntyre, P. (2003). Is low immunisation coverage in inner urban areas of Australia due to low uptake or poor notification? Australian Family Physician, 32(12), 1041-1043.
  • Lawrence, G., MacIntyre, C., Hull, B., McIntyre, P. (2003). Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia. Australian and New Zealand Journal of Public Health, 27(4), 413-418. [More Information]
  • McIntyre, P. (2003). Pneumococcal disease. In Thomson (Eds.), The health of Indigenous Australians, (pp. 384-396). VIC: Oxford University Press.
  • Horby, P., Gilmour, R., Wang, H., McIntyre, P. (2003). Progress towards eliminating Hib in Australia: An evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Communicable Diseases Intelligence Quarterly Report, 27(3), 324-341.
  • Leask, J., McIntyre, P. (2003). Public opponenets of vaccination: A case study. Vaccine, 11, 4700-4703. [More Information]
  • Lawrence, G., Menzies, R., Burgess, M., McIntyre, P., Wood, N., Boyd, I., Purcell, P., Isaacs, D. (2003). Survellance of adverse events following immunisation: Australia 2000-2002. Communicable Diseases Intelligence Quarterly Report, 27(3), 307-323.

2002

  • MacIntyre, C., Gay, N., Gidding, H., Hull, B., Gilbert, G., McIntyre, P. (2002). A mathematical model to measure the impact of the Measles Control Campaign on the potential for measles transmission in Australia. International Journal of Infectious Diseases, 6, 277-282. [More Information]
  • Elliott, E., McIntyre, P., Ridley, G., Morris, A., Massie, J., McEniery, J., Knight, G. (2002). Hospitalised pertussis in infancy. RACP Annual Scientific Meeting, : British Medical Journal Publishing Group.
  • Hull, B., Lawrence, G., McIntyre, P., MacIntyre, C. (2002). Immunisation Coverage: Australia 2001. Australia: University of Sydney.
  • Turnbull, F., McIntyre, P., Achat, H., Wang, H., Stapledon, R., Gold, M., Burgess, M. (2002). National study of adverse reactions after vaccination with Bacille Calmette-Guerin. Clinical Infectious Diseases, 34(4), 447-453. [More Information]
  • Jones, C., Isaacs, D., McIntyre, P., Cunningham, A., Garland, S. (2002). Neonatal herpes simplex virus infection. Ninth Annual Report, , 31-32.
  • Torvaldsen, S., McIntyre, P. (2002). Observational methods in epidemiologic assessment of vaccine effectiveness. Communicable Diseases Intelligence Quarterly Report, 26(3), 451-457.
  • Nolan, T., McIntyre, P., Roberton, D., Descamps, D. (2002). Reactogenicity and immunogenicity of a live attenuated tetravalent measles - mumps - rubella-varicella (MMRV) vaccine. Vaccine, 21(3-4), 281-289. [More Information]
  • McMaster, P., McIntyre, P., Gilmour, R., Gilbert, G., Kakakios, A., Mellis, C. (2002). The emergence of resistant pneumococcal meningitis - implications for empiric therapy. Archives of Disease in Childhood, 87(3), 207-211. [More Information]
  • Torvaldsen, S., Hull, B., McIntyre, P. (2002). Using the Australian Childhood Immunisation Register to track the transition from whole-cell to aceullular pertussis vaccines. Communicable Diseases Intelligence Quarterly Report, 26(4), 581-583.

2001

  • Gilbert, G., Turnbull, F., McIntyre, P., Burgess, M., Escott,, R., Gidding, H., Heath, T. (2001). Impact of the Austalian measles control campaign on immunity to measles and rubella. Epidemiology and Infection, 127, 297-303.
  • MacIntyre, C., McIntyre, P. (2001). MMR, autism and inflammatory bowel disease: responding to patient concerns using an evidence-based framework. Medical Journal of Australia, 175, 127-128.
  • Turnbull, F., Burgess, M., McIntyre, P., Gilbert, G., Hull, B., Lambert, S., Gidding, H., Escott,, R., Achat, H., Wang, H., et al (2001). The Australian measles control campaign 1998. Bulletin of the World Health Organization, 79, 882-888.

2000

  • Hull, B., McIntyre, P. (2000). A re-evaluation of immunisation coverage estimates from the Australian Childhood Immunisation Register. Communicable Diseases Intelligence Quarterly Report, 24(6), 161-164.
  • McIntyre, P., Nolan, T. (2000). Conjugate pneumococcal vaccines for non-indigenous children in Australia. Medical Journal of Australia, 173, S54-S57.
  • Guthridge, S., McIntyre, P., Isaacs, D., Hanlon, M., Patel, C. (2000). Differing serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian Aboriginal and Caucasian infants - implications for disease epidemiology. Vaccine, 18, 2584-2591.
  • McIntyre, P., Gilmour, R., Gilbert, G., Kakakios, A., Mellis, C. (2000). Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997-1999. Medical Journal of Australia, 173, 2-6.
  • Hull, B., McIntyre, P. (2000). Immunisation coverage reporting through the Australian Childhood Immunisation Register - an evaluation of the third-dose assumption. Australian and New Zealand Journal of Public Health, 24(1), 17-21. [More Information]
  • McIntyre, P., Gidding, H., Gilbert, G. (2000). Measles in an era of measles control. Medical Journal of Australia, 172, 103-104.
  • McIntyre, P. (2000). Meningitis. In Virginia A. Moyer et al (Eds.), Evidence Based Pediatrics and Child Health, (pp. 197-205). BMJ Books.
  • Hanlon, M., Nambiar, R., Kakakios, A., McIntyre, P., Land, M., Devine, P. (2000). Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole-call pertussis ELISA. Immunology and Cell Biology, 78, 254-258.
  • Thomas, P., McIntyre, P., Jalaludin, B. (2000). Survey of pertussis morbidity in adults in western Sydney. Medical Journal of Australia, 173, 74-76.
  • Lister, S., McIntyre, P., Menzies, R. (2000). The epidemiology of respiratory syncytial virus infections in NSW children, 1992-1997. NSW Public Health Bulletin.
  • McIntyre, P., Amin, J., Gidding, H., Hull, B., Torvaldsen, S., Tucker, A., Turnbull, F., Burgess, M. (2000). Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998. Communicable Diseases Intelligence Quarterly Report, 24, 276-277.
Back to Top

To update your profile click here. For support on your academic profile contact .